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Major histocompatibility complex (MHC) class Ib molecules share similar 
structure with the classical MHC class Ia molecules, but they generally have low 
expression levels and limited tissue distributions. Nevertheless, there are many different 
class Ib molecules and the well-studied ones have various specific functions. Many Ib 
molecules remain to be studied. 
Increasing evidence shows that MHC class Ib molecules can restrict CD8+ T cell 
responses during infections, just as the classical MHC class Ia molecules do. In this 
thesis, classical MHC class I deficient mice were employed to study the MHC class Ib 
restricted anti-lymphocytic choriomeningitis virus (LCMV) responses. The mice were 
able to generate CD8+ T cell dependent immune response to the acute viral infection and 
partially control the infection in the early phase. IFN! and granzyme B were produced in 
vivo by the CD8+ T cells. The response was restricted by MHC class Ib molecules as 
indicated by in vitro restimulation assays. However, the mounted responses were not 
strong enough to fully control the viral infection such that the infection becomes chronic 
in these mice and antigen-specific CD8+ T cells gradually lost their ability to produce 
cytokines and survive.  
One MHC class Ib molecule, H2-T11, was selected to test an approach for 
studying MHC class Ib systematically. H2-T11 has high similarity to the Qa-1b encoding 
gene, H2-T23. Reverse-transcriptional PCR and quantitative-PCR showed that it was 
expressed at relatively high levels in mouse spleen, thymus, and intestine. The transduced 
hybrid T11 molecule containing an antibody-recognizable H2-Db "3 domain could be 
detected on both TAP+/+ Hela and TAP-/- T2 cell surfaces. The hybrid T11 expressing 
cells were not able to present insulin to the 6C5 T cell hybridoma, while the hybrid T23 
expressing cells did. While T23 required Qdm peptide for its in vitro folding, T11 could 
fold in the absence of Qdm peptides. However, in the presence of Qdm, the folding 
efficiency was higher. Multiple peptides were eluted from the hybrid T11 and T23 
expressing Hela cells. Qdm was found in both T11 and T23 peptide pools, but it was 
much more frequently found from T23 pool. Fewer peptides were eluted from T11 than 
T23. The T11-Qdm tetramers could not recognize NK or NKT cells, but the T23-Qdm 
tetramers could. Together, these studies indicated that T11 might be a functional paralog 
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The major histocompatibility complex (MHC) was first described in the 1940s 
during organ transplantation research. It is a ~4Mb gene region containing a set of genes 
encoding proteins with antigen presentation function. This gene region has been found in 
all investigated vertebrates, such as mouse, chicken, frog and bony fish (1, 2). Human 
MHC molecules are also called human leukocyte antigens (HLA), and they are located on 
the short arm of chromosome 6. In the well-studied experimental animal, house mouse, 
the MHC is located on chromosome 17, and names usually start with “I” or “H2” due to 
historical reasons. The MHC region encodes three types of MHC genes, MHC class I, II 
and “III”. The MHC class I and II encode proteins belonging to the immunoglobulin-like 
protein family. They are capable of binding antigens, usually short peptides, in their 
binding groove and present these antigens to T cells. The MHC class III region encodes 
various proteins that do not have antigen presentation functions but are generally related 
to immune response.  
The various MHC genes were generated by gene duplication during evolution. 
They can be classified as “old,” “middle-aged,” and “young” MHCs (3). The old ones 
were generated long ago, and their original function retained. The middle-aged genes 
gathered multiple mutations after the original duplication. Some of them become very 
polymorphic and usually have multiple allels. They may co-evolute with the pathogens 
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under selection pressures to retain their abilities to bind specific peptides derived from 
pathogens (4, 5). Some of the mutations may be harmful and these genes are thought to 
become pseudogenes. The “young” MHCs are the ones duplicated recently; the new 
generated genes may still have the same functions as the parent gene, because there are 
not enough mutations accumulated to lead to a functional change.  
The function of MHC molecules is closely related to T cells. T cells are derived 
from the hematopoietic stem cells in the bone marrow. After the differentiation of 
common lymphoid progenitor cells to T cell progenitors in the bone marrow, immature T 
cells migrate to the thymus for further development. The successful maturation of T cells 
requires their contact with MHC class I or II molecules expressed on thymus epithelial 
cells and dendritic cells. After positive selection and negative selection processes, the T 
cells with proper affinity for self-MHC are selected in the thymus and migrate to the 
peripheral. In the peripheral, the T cells will survail the environment for antigens through 
interactions between TCR and MHC. MHC deficient mice have significantly decreased T 
cell output from the thymus and have much fewer T cells in their peripheral than the wild 
type animal (6-10). In the peripheral, mature T cells require contact with MHC for their 
survival and activation (11, 12).  
 
MHC class II 
MHC class II molecules are expressed in professional antigen presenting cells 
(APCs), such as dendritic cells, macrophages, and B cells. MHC class II expression is 
controlled by a master transcription factor CIITA. In CIITA deficient hosts, the MHC 
class II molecules are not expressed (13). Class II molecules are composed of two equal-
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weighted " and # chains. The "1 and #1 domains form the peptide-binding groove, 
which has a #-sheet bottom and two "-helix walls. The groove is an open tunnel and can 
accommodate peptides of 10 to 30 amino acids long or even longer (14). Usually, these 
peptides are generated from exogenous proteins that are internalized in the cells by 
endocytosis or phagocytosis. The internalized proteins are trapped inside the phagosomes 
or endosomes. The class II molecules are assembled in the endoplasmic reticulum (ER) 
and stabilized by the invariant chain (Ii) that occupies the class II peptide-binding groove. 
The assembled MHC class II is secreted through the Golgi complex to the MHC class II 
compartment (MIIC) (15, 16). The phagosome/endosome containing the exogenous 
proteins will fuse with MIIC. The exogenous proteins are degraded to small peptides by 
the proteases and peptidases in the MIIC. Invariant chain is also cleaved and a short 
peptide, CLIP, is left inside the MHC class II binding groove. Then the CLIP is replaced 
by an exogenous peptide with the help of a nonclassical MHC class II molecule, DM (17, 
18). The MHC class II with the exogenous peptide is further transported to the cell 
membrane surface, where the peptide is presented by MHC class II to T cell receptors 
(TCR) on CD4+ T cells. The MHC class II and TCR interaction is required for the 
selection of CD4+ T cells in the thymus, and the interaction initiates the downstream 
TCR signaling to activate CD4+ T cells in the periphery. Besides exogenous proteins, 
intracellular proteins, including self-proteins and pathogen proteins, can also be 






MHC class I 
MHC class I molecules are expressed on almost all nucleated cells. They are 
composed of a heavy chain and a smaller #-2-microglobulin (#2m) subunit. The heavy 
chain "1 and "2 domains form the peptide-binding groove similar to the one of MHC 
class II except that class I groove has closed ends. In most instances, only short peptides 
8 to 10 amino acids in length can fit into the MHC class I binding groove. The class I 
molecules are synthesized by ribosomes on the rough ER. The MHC class I peptides are 
usually generated from cytoplasmic proteins, such as proteins of intracellular microbes or 
mis-folded self-proteins. These proteins are degraded by the proteasome to peptides and 
further trimmed by proteases and peptidases in the cytosol. The short peptides are 
transported into the ER through the transporter associated with antigen processing (TAP), 
which is a heterodimer formed by TAP-1 and TAP-2 proteins. As a member of ATP-
binding cassette family, TAP consumes ATP to transport peptides from cytosol into ER 
(22). Inside the ER, the peptides are further trimmed by endoplasmic reticulum 
aminopeptidase associated with antigen processing (ERAAP), and loaded onto the MHC 
class I molecules with the help of Tapsin and ERp57 (23). The assembled MHC class I 
molecules are transported through the Golgi complex to the cell surface and the peptides 
are presented to TCRs on CD8+ T cells. The classical mouse MHC class I molecules 
include H2-D, H2-K and H2-L. MHC class I deficient mice are generally CD8+ T cell 
deficient due to the lack of MHC class I selection in the thymus. In the C57BL/6 mice, 
which are of the b haplotype, the L gene is not expressed because of a large deletion in 
the L gene. Thus, the Kb-/-Db-/- mice on the B6 background are MHC class I deficient and 
have very few CD8+ T cells. 
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The class I MHC is subdivided to two groups: classical MHC class I (MHC class 
Ia) and nonclassical MHC class I (MHC class Ib). The Ia molecules are ubiquitously 
expressed at high levels and they are very polymorphic. Ia molecules are very well 
studied and all the basic characterization of MHC class I is based on Ia. The nonclassical 
MHC class I molecules share similar structure to the classical ones. Most Ib molecules 
are encoded at the telomeric end of the MHC region. They are less polymorphic 
compared to the Ia molecules. Ib molecules usually have limited tissue distribution and 
their expression levels on the cell surface are lower than Ia. The mouse telomeric end of 
MHC is separated to three regions: H2-Q region, H2-T region and H2-M region. Each 
region encodes multiple MHC class Ib genes. Some Ib molecules are encoded outside 
MHC, such as CD1 and MR1. They also fold with #2m to form an MHC structure. 
Despite the low expression level and constrained expression in tissues, MHC class Ib 
molecules have some interesting functions. More and more studies in both human and 
mouse have shown that Ib molecules participate in the host anti-pathogen immune 
response and tumor surveillance (24-32).  
 
CD1 
CD1 molecules are encoded outside MHC region, and they are conserved in 
mammals (33). Humans express six forms of CD1, CD1a-CD1e. CD1d is the only form 
expressed in mice. CD1d molecules in mice, as well as CD1a-CD1d molecules in human, 
bind lipid antigens as opposed to peptide antigens. CD1 ligands include glycolipids, 
lipopeptides, and even inorganic compounds with alkyl tails. These ligands all have an 
alkyl component that can fit into the hydrophobic ligand-binding groove of CD1. Crystal 
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structures show that the CD1 groove is narrower and deeper than the peptide binding 
groove of classical MHC class I molecules (34). CD1d molecules select a special group 
of T cells, named natural killer T cells (NKT), which express both TCRs and the natural 
killer cell receptor, NK1.1 (35, 36). The majority of NKT cells exclusively utilize TCR 
V"14-J"18 in mice and V"24-J"18 in humans as their " chain and have a limited usage 
of specific TCR # chains. NKT cells can respond to pathogen infections rapidly and 
robustly by producing large amount of IFN! cytokine, and granzyme B/perforin cytotoxic 
factors. The TCRs on NKT cells recognize the lipid antigens presented by CD1d 
molecules. Although CD1 molecules have a similar structure to MHC class Ia, they use 
different pathways for antigen presentation. CD1 molecules are synthesized inside the 
ER, and bind to self lipid, they are transported to the cell surface through the Golgi 
complex; surface CD1 then can be endocytosed back to endocytic compartments; after 
that they are sorted to the compartments containing foreign lipid antigens, where the self 
-lipid can be replaced with a foreign one; the new complex is secreted back to the cell 
surface, where the foreign lipid antigen is presented by CD1 to NKT cells (37). Unlike 
the protein antigens, almost all the lipid antigens with large alkyl chains are hydrophobic, 
that raises the question of how the lipid antigens are delivered to the antigen presenting 
cells. It was discovered that the apolipoproteins, which are the lipid transporters in the 
serum and transport lipids between liver and other tissues and organs for metabolism, can 
deliver lipid antigen cargo to antigen presenting cells. APCs can secrete ApoE to capture 
the nearby lipid antigens, and ApoE can be endocytosed through a specific receptor to 





H2-M3 is encoded in the M region of mouse MHC complex. It preferentially 
binds N-formylated peptides from bacterial or mitochondrial proteins. Although H2-M3 
can bind normal peptides, the affinity is ~1000-fold lower than the binding affinity of N-
formylated peptides; H2-M3 restricted CTLs kills N-formylated peptide pulsed target 
cells better than nonformylated peptide pulsed ones (39, 40). H2-M3 was not detectable 
constitutively on the cell surface, and it appears to remain inside the cell until the proper 
N-formylated ligand is provided, after which H2-M3 is transported to the cell surface 
(41). H2-M3 was first found to participate in immune responses against Listeria 
monocytogenes by presenting Listeria peptides to CD8+ T cells (42-44). Kb-/-Db-/- mice 
were reported to control L. monocytogene infection as well as wild type mice, but H2-M3 
didn’t seem to be critical for the defense; other MHC class Ib might also contribute to the 
anti-Listeria response, as demonstrated in Kb-/-Db-/-H2-M3-/- mice (30, 45, 46). H2-M3 
restricted CD8+ T cells respond to primary intracellular bacterial infection rapidly, 
indicating that they may bridge the innate and adaptive immune responses, but they seem 
to lack memory (47-49). Specific CD8+ T cells are selected by H2-M3 in the thymus and 
selection requires N-formylated peptides (50). It was shown that these CD8+ T cells 
could be selected by either thymic epithelial cells or the bone marrow-derived 
hematopoietic cells. The cells selected by H2-M3 on thymic epithelial cells had normal 
CD8+ T cell properties in reaction to pathogenic antigens. The cells selected by H2-M3 
on hematopoietic cells could react faster than other CD8+ T cells, and they did not form 
protective memory responses (51). Besides Listeria, H2-M3 restricted anti-Mycobacteria 
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tuberculosis CD8+ T cell response could also be elicited by immunizing the mice with 
dendritic cells pulsed with Mycobacteria N-formylated peptides (52).  
 
Qa-2  
Qa-2 is encoded by four different genes in the Q region, H2-Q6/8 and H2-Q7/9. 
Q6 and Q8 are highly conserved; and Q9 and Q7 are similar to each other (53-55). They 
are probably new divided genes that have not evolved enough to be distinct from each 
other. The surface expression of Qa-2 is TAP dependent (56). Qa-2 is ubiquitously 
expressed on nucleated cells; these molecules are also expressed in some special 
locations where classical MHC class I is not expressed, such as embryo, placenta, hair 
follicle, etc. (57). Qa-2 is special in that unlike other MHC class I molecules, which have 
transmembrane tails, Qa-2 is fixed on the cell surface by GPI linkers; Qa-2 molecules can 
also be found in the extracellular matrix as a soluble protein (58). Qa-2 molecules are 
relatively polymorphic. They can bind various peptides that share a peptide sequence 
motif. The peptides are usually of 8 to 10 amino acids long like the classical MHC class I 
ligands. Position 7 (P7) and position 9 (P9) are important anchor positions, and P7 
usually is His, whereas P9 prefers Leu, Ile and Phe (59, 60). The crystal structure shows 
that Qa-2 has a relatively shallower binding groove than classical MHC class I (57). Qa-2 
might participate in the development of CD8""+ TCR"#+ intestinal epithelial 
lymphocytes (IELs) as the number of IELs was reported to be very low in the Qa-2 
deficient mice BALB/cAnN, but BALB/cAnN mice with Q9 transgene have significantly 
increased IEL cell number (61). Qa-2 was found to be a key factor in controlling polyoma 
virus infection in MHC class Ia deficient mice (62). A subset of CD8+ T cells was 
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observed to be specifically reactive to H2-Q9 with a peptide from the polyoma virus 
VP2 capsid protein. The H2-Q9 restricted VP2 specific CTLs expand for about 3 months 
post infection and they are maintained at high level during chronic PyV infection (63). 
Qa-2 was also reported to be involved in the control of tumor cells (64).  
 
TLA 
Thymic leukemia antigen (TLA) is encoded by H2-T18d, T3b, T3d, Tlaa-1, Tlaa-2 
and Tlaa-3 genes (65). It is exclusively expressed in thymus, intestine and T cell 
lymphoma cells (65). It does not require TAP for cell surface expression and the 
engagement with peptides is also not required for stable folding and expression (66-68). 
In contrast to MHC class Ia, which interacts with CD8"#+ T cells, TLA tetramer can 
specifically recognize a group of cells expressing CD8"", especially intestinal 
intraepithelial lymphocytes (IEL) (69). The crystal structure shows that due to the 
conformational change, the TLA peptide binding groove is closed, preventing peptide 
binding. More interestingly, TLA does not interact with TCR, but directly interacts with 
the CD8"" homodimer with high affinity through the TLA "3 domain (70, 71). The 
interaction between TLA and CD8"" regulates the IEL function such that TLA-/- mice 
showed severe colitis in TLA-/-TCR"-/- mice, although TLA-/- mice of wild type 
background have normal numbers of IEL and do not develop colitis spontaneously (72). 
Recent research suggests that TLA can also regulate CD4+ T cell function in the intestine 
to promote the IL-17 production, and this interaction can protect mice from Citrobacter 





Like TLA, MR1 is also abundant in the intestine, though MR1 is expressed 
ubiquitously in many tissues. MR1 was first discovered in humans, and later was found in 
rat and mouse (74-76). It is conserved in many mammals (77), and it is not polymorphic 
(78). The "1 and "2 domains, which usually form the peptide-binding groove, are very 
close in amino acid sequence to the domains of classical MHC class I (74). Just like the 
classical MHC class I, MR1 also associates with #2m to form a stable structure (79). 
Although MR1 seems to have antigen-presenting function (80), no MR1 ligand has been 
found. The most important discovery about MR1 is that it can select mucosal-associated 
invariant T cells (MAIT). MAIT cells are abundant in the gut lamia propria; they might 
be selected in the thymus in small numbers and expand in peripheral to reach a large 
population in the intestine (81). The development of MAIT requires MR1 molecules 
expressed on B cells (82). The successful generation of MAIT is also dependent on 
commensal bacteria, which indicates that the MR1 bound ligand may originate from the 
commensal bacteria (82). Like the NKT cells selected by CD1 molecules, MAIT cells 
also have limited TCR " chain usage, such that human MAIT exclusively express V"7.2-
J"33, and mouse MAIT express V"19-J"33. The human MAIT cells are either CD4-
CD8- or CD8""+, but unlike the TLA interacting CD8"", MAIT CD8"" does not bind 
MR1 molecules (83). The study of V"19i transgenic mice show that MAIT cells can 
produce IL-4, IL-5, IL-10 and IFN! shortly after TCR signaling, indicating they may be 
more innate-like (84); V"19i T cells were also reported to be involved in the suppression 
of experimental autoimmune encephalomyelitis (EAE) that MR1-/- mice had exacerbated 
EAE (85). Although MR1 is an MHC class I molecule, the MR1 expression on the cell 
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surface and MAIT cell activation was found to be independent on MHC class I 
antigen-processing machinery, such as the proteasome, TAP, tapsin, and calreticulin; 
instead, invariant chain (Ii) and DM, which are critical components for MHC class II 
antigen processing, were reported to be important for MR1 expression and MAIT cell 
activation (86). MR1 is conserved in mammals, and MAIT cells selected by MR1 are also 
conserved to the extent that human and mouse MAIT can cross-react with MR1 from 
each other and also MR1 molecules from other mammals (81).  
 
Qa-1b 
Qa-1 is another MHC class I gene encoded in the mouse H2-T region. There are 
four different haplotypes of Qa-1 (a, b, c and d); a and b haplotypes are encoded in the 
majority of the mouse strains, and the b haplotype is more prevalent (87). Qa-1b in mouse 
and its human homolog HLA-E are the most well-studied MHC class Ib molecules. Qa-1b 
is encoded by the mouse H2-T23 gene. It is ubiquitously expressed in a TAP independent 
manner, but its expression level is relatively low compared to classical MHC molecules. 
Qa-1b /HLA-E have a specific peptide ligand, which is named as Qa-1 determinant 
modifier (Qdm) (88, 89). Qdm is a nonomer peptide derived from the signal sequence of 
other MHC class I molecules, such as HLA-A2, H2-D and H2-L; amino acids at position 
2 and 9 of the nonomer are important for Qdm binding to the Qa-1b molecule (90). 
Although Qa-1b cell surface expression is independent of TAP, TAP is required for the 
presentation of Qdm (91, 92). It is possible that Qdm is cleaved and left outside the ER 
when the class I molecules are synthesized by the ribosomes on rough ER (92).  
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Qdm is presented by Qa-1b /HLA-E to CD94/NKG2 receptors on NK cells, NKT cells 
and some activated T cells (93-96). CD94/NKG2 is a receptor family expressed on NK 
cells, and CD94 is covalently linked to NKG2 by disulfide bonds (97). The family 
includes CD94/NKG2A, CD94/NKG2C and CD94/NKG2E, and all three can interact 
with Qa-1b /Qdm. The cytoplasmic end of NKG2A contains immuno-receptor associated 
tyrosine-based inhibitory motif (ITIM) that upon interaction with Qa-1b /Qdm, 
CD94/NKG2A will initiate inhibitory signals to downstream pathways which leads to the 
inhibition of NK cell function. NKG2C and NKG2E have short cytoplasmic tails that do 
not contain ITIM, but the two receptors are noncovalently associated with DAP12, which 
has an immuno-receptor associated tyrosine-based activation motif (ITAM) (98). The 
interaction between Qa-1b /Qdm and CD94/NKG2C or CD94/NKG2E may induce NK 
cell activation signals (99). The NK cell status is dependent on the balance of activation 
and inhibitory signals. Although NKG2A, NKG2C and NKG2E are expressed by about 
half of the total natural killer cells, NKG2A has a much higher expression level than 
NKG2C and NKG2E, thus the Qa-1b /Qdm interaction with NK cells usually leads to the 
inhibition of NK cell function (98).  
Because MHC class Ia molecules express Qdm in their leader sequence, when 
viral infection of cells or cell tumorization lead to reduced MHC class Ia expression, the 
Qdm peptide will also be reduced, such that the Qa-1b /Qdm interaction with NK cells 
will be interrupted. This may lead to the activation of NK cells to kill the viral infected 
cells or tumor cells (100). Although Qdm is the dominant peptide that Qa-1b /HLA-E 
bind, they do have the ability to bind various peptides other than Qdm (101, 102). Qdm 
appears to have an ideal sequence motif for binding to Qa-1b /HLA-E, yet the binding 
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complex still has a very fast dissociation rate, requiring constant formation of new 
complexes to maintain cell surface expression and inhibit NK cell activation (103). 
Besides binding Qdm, Qa-1b is also involved in anti-bacterial responses. CD8+ T cells 
from Listeria monocytogene infected mice were able to kill L. monocytogene infected 
target cells and the restriction element was Qa-1b (104). Qa-1b was also recognized by a 
group of CTLs in anti-Salmonella typhimurium responses in mice (105), and a group of 
HLA-E restricted CTLs were also found within the PBMC population of cells of 
individuals who have been vaccinated with Salmonella vaccine Ty21a (106). The 
Salmonella peptide bound to Qa-1b was encoded in the bacterial chaperone, GroEL. The 
GroEL specific CD8+ T cells restricted by Qa-1b also cross-reacted with a peptide from 
mammalian hsp60 protein (25). The hsp60 peptide GMKFDRGYI is the dominant 
peptide bound to Qa-1b when Qdm is absent (107). Qa-1b was also found to be essential 
for the control of mouse poxvirus infection, such that H2-T23-/- mice had a much higher 
ectromelia virus titer than wild type mice after infection (108). Interestingly, it was found 
that Qa-1b could also present insulin to activate a subset of CD8+ T cells and those T 
cells were naturally selected in mouse thymus by Qa-1b (109, 110). A recent study also 
indicated that Qa-1b can restrict CTL responses against antigen-processing deficient cells, 
and that the peptides presented by Qa-1 on the TAP-/- cells might be different from those 
from TAP+/+ cells (111). Qa-1b on a population of activated CD4+ T cells has also been 
reported to bind peptides originating from the TCR V#8 chain and to present these 
peptides to regulatory CD8+ T cells; the regulatory CD8+ T cells can inhibit CD4+ T 
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 CHAPTER 2 
MHC CLASS IB RESTRICTED ANTI-LCMV T CELL RESPONSES 
Abstract 
MHC class Ib molecules have low expression level and limited tissue distribution, 
nevertheless, some CD8+ T cells are restricted by MHC class Ib. Class Ib restricted 
CD8+ T cells were reported to participate in immune responses against bacterial 
infections. There have been limited studies on the role MHC class Ib restricted T cells in 
anti-viral responses. In this study, Kb-/-Db-/- and Kb-/-Db-/-CIITA-/- mice, which only 
express the MHC class Ib molecules but not the class Ia molecules, were used to study 
the MHC class Ib restricted anti-LCMV response. LCMV was partially but not 
completely cleared during the early phase of the acute infection in the Kb-/-Db-/-CIITA-/- 
mice, while the virus infection was not controlled in the Kb-/-Db-/-#2m-/- mice. Clearance 
was dependent on CD8+ T cells. CD8+ T cells responded by expansion, producing IFN! 
and granzyme B. In vitro assays demonstrated that the CD8+ T cell responses were 
restricted by MHC class Ib molecules. The CD8+ T cells in wild type mice expanded and 
contracted to a constant level, and memory responses were detected by in vitro assays. 
The CD8+ T cell number in the Kb-/-Db-/-CIITA-/-  mice continued to drop and the CD8+ T 





CD8+ T cells play critical roles in the host immune response to infections. They 
are selected by MHC class I molecules in the thymus. CD8+ T cells in the periphery 
expand upon infection to increase their numbers in a few days. The effector CD8+ T cells 
interact with antigens presented by MHC class I molecules through the TCR, and respond 
by producing large amounts of IFN! and TNF", and perforin/granzyme B cytotoxic 
factors. After the expansion, which lasts for about 1 week, majority of the CD8+ T cells 
die by apoptosis leaving ~5% of the cells alive and becoming long-live memory cells (1, 
2). These principles were determined from the studies of CD8+ T cells restricted by 
classical MHC class I molecules, and little is known about the CD8+ T cells restricted by 
nonclassical MHC class I. The nonclassical MHC class I restricted CD8+ cells naturally 
occur in animals and they represent a small percentage of the total CD8+ T cell 
population (3). The numerically dominant conventional CD8+ T cells may compete with 
the Ib-restricted CD8+ T cells for niche, cytokines and other factors that are important for 
CD8+ T cells survival (4, 5). In Kb-/-Db-/- mice, which do not express MHC class Ia and 
thus do not have Ia-restricted T cells, the CD8+ T cells are much fewer than in wild type 
mice, but these CD8+ T cells are restricted by MHC class Ib molecules in theory (6). In 
naïve Kb-/-Db-/-CIITA-/- mice, which do not express either MHC class Ia or MHC class II, 
CD8+ T cells were significantly expanded compared to the ones in Kb-/-Db-/- mice (7, 8). 
The increased CD8+ T cells in Kb-/-Db-/-CIITA-/- mice were observed to arise from 
homeostatic expansion. CD8+ T cells in both Kb-/-Db-/- and Kb-/-Db-/-CIITA-/- mice express 
high level of CD44, CD122 and Ly6C, and behave like memory cells (8). Class Ib 
 !
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restricted CD8+ T cells were reported to participate in host anti-bacteria responses (9-16). 
Their role during virus infection was rarely studied (17, 18).  
LCMV belongs to Arenovirus family. It is an ambisense RNA virus containing 
two genomic RNAs. The RNA genome encodes four proteins: glycoprotein (GP), 
nucleoprotein (NP), the RNA polymerase (L protein) and a protein required for the virus 
budding (Z protein) (19). LCMV is widely used in studies of anti-viral immune 
responses. The dominant peptide specificities in the CD8+ T cell response in C57BL/6 
mice are NP396 (FQPQNGQFI), which binds H2-Db, and GP33 (KAVYNFATM), which 
is a ligand for both H2-Db and H2-Kb. The Kb/Db restricted CD8+ T cells response 
against NP396 and GP33 accounts for half of the CTL response during LCMV acute 
infection (20, 21). There are many different strains of LCMV isolated after the first 
discovery of the virus. Armstrong and clone 13 are both common laboratory strains. 
There are only two amino acids difference between LCMV-Arm and LCMV-CL13, but 
LCMV-Arm causes an acute infection in their natural rodent host, while LCMV-CL13 
causes protracted or chronic infections that require several months for the host to clear 
the virus (22-24).  
Although MHC class Ia restricted CD8+ T cell response are critical for control of 
pathogen, more and more studies show that MHC class Ib molecules also play an 
important role in the host defense against microbial infections. For example, H2-M3 
restricted anti-Listeria CD8+ T cells (9, 10, 25, 26). Qa-1b restricted CD8+ T cells were 
found in Salmonella infected hosts (12, 13). In addition, H2-Q9, which encodes Qa-2, 
was found to be an important restriction element of CD8+ T cell response to the polyoma 
virus infection (17, 27). These findings lead to the question of whether MHC class Ib is 
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involved in other anti-viral responses, whether it is generally true that MHC class Ib 
participates in host anti-viral responses, how do Ib molecules participate in the response, 
and how important their participation is.  
In this study, we used LCMV-Arm virus as a model pathogen to investigate the 
participation of MHC class Ib restricted CD8+ T cells in the host anti-viral response.  
Materials and methods 
Mice 
C57BL/6, CIITA-/-, #2M-/-, and B6.K1(Qa-2-/-) mice were obtained from Jackson 
Laboratory. The CIITA-/- mice were backcrossed with C57BL/6 mice for 7 generations 
(Jackson Lab). Kb-/-Db-/- mice were backcrossed to C57BL/6 mice for 10 generations and 
were obtained from Taconic Farm (6). Kb-/-Db-/-CIITA-/- mice and Kb-/-Db-/-#2M-/- mice 
were generated by crossing Kb-/-Db-/- mice with either CIITA-/- mice or #2M-/- mice (8). 
B6.129S6-H2-T23tm1Cant/J mice, which are Qa-1-/-, were a gift from Dr. Harvey Cantor 
(Harvard). CD1d-/- mice were a gift from Dr. Luc Van Kaer (Vanderbilt University). H2-
M3-/- mice were a gift from Dr. Chyung-Ru Wang (Northwestern University). Mice 8-12 
weeks old were used in the experiments. Both male and female mice were used in the 
LCMV clearance studies; the mice were sex-matched in all the other experiments. Mice 
were housed in a specific pathogen-free facility at the University of Utah and were 
handled according to the IACUC policies. 
Cell lines 
Vero cells and BHK-21 cells were cultured in DMEM media supplemented with 
10% fetal bovine serum, 100 U/ml penicillin, 100 $g/ml streptomycin and 292 µg/ml L-
glutamine (Invitrogen). Mouse primary cells were cultured in RPMI-1640 media 
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supplemented with 10% fetal bovine serum, 100 U/ml penicillin, 100 $g/ml 
streptomycin, 292 µg/ml L-glutamine, 100 µM nonessential amino acids, 1 mM sodium 
pyruvate, and 55 µM 2-mercaptoethanol (Invitrogen). All the cells are maintained in 
humidified 37°C, 5% CO2 incubator. 
Virus and infection 
LCMV-Armstrong virus was a gift from Dr. Matthew Williams (University of 
Utah). Virus was maintained in BHK-21 cells, and the titer was obtained by Vero cell 
plaque assay (28). Briefly, 6x105/well Vero cells were seeded in 6-well plate (Corning 
Costar) 1 day before the plaque assay, so that they would form confluent monolayers; 
virus stock were 10-fold serially diluted in DMEM media, and 200 µl of the diluted virus 
was added on top of the Vero cell monolayer; the plate was incubated for 1 hour before 
the addition of 0.5% agarose in 199 media (Invitrogen); 4 days later, 0.5% agarose in 199 
media containing neutral red was added to the plate, and the plaque number was counted 
the following day. The infection of mice was achieved by intraperitoneal inoculation with 
LCMV-Armstrong virus in a dose of 2x105 PFU/mouse in 200 µl of sterile PBS. At 
certain time points after the infection, mouse tissues were harvested for the desired 
experiments. Tissues collected for plaque assay were weighed and homogenized in 
DMEM media, followed by 10-fold serial dilutions and incubation with Vero cell 
monolayers to determine virus titers as described (28). 
Antibodies and flow cytometry 
Mouse-specific TCR# (H57-597), CD4 (GK1.5, RM4-5), CD8" (53-6.7), IFN! 
(XMG1.2), Granzyme B (16G6) monoclonal antibodies, and TCR V# panel antibodies 
conjugated with FITC, PE, PerCP, APC, PerCP-Cy5.5, PE-Cy5, PE-Cy7, pacific blue or 
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Alexafluor488 fluorophore were purchased from BD Bioscience or eBiosience. 
Suspended single cells were stained with antibodies for detecting surface proteins in 4°C 
for 20 min. If necessary, intracellular staining was done after surface staining by the BD 
Cytofix/Cytoperm Fixation/Permeabilization Solution Kit according to the manufacture’s 
instructions. Cells were fixed by 1% paraformaldehyde in PBS after the staining. The 
fluorescence was detected by FACS Canto II machine (BD Bioscicence) and the data 
were analyzed by Flowjo software (Tree Star).   
The MR1 blocking antibody (26.5) used in in vitro stimulation assay was a gift 
from Dr. Ted Hansen (Washington University School of Medicine). 
CD8+ T cell depletion 
Mice were intraperitoneally injected with 300 µg CD8 monoclonal antibody 
(2.43) in PBS at day -3, -2, -1 before the LCMV infection, and at day 6 after the LCMV 
infection. The depletion efficiency was %95% based on analysis by flow cytometry. 
In vitro restimulation assay 
Peritoneal macrophages or bone marrow-derived macrophages were used as 
antigen presenting cells in the assay. To harvest the peritoneal macrophages, mice were 
i.p. injected with 100 µg concanavalin A (ConA) in 200 µl PBS; 3 days after the 
injection, peritoneal exudates were harvested and 4x105 cells were plated in one well of 
the 96-well plate; 2 hours after incubation, nonadherent cells were washed away and the 
remaining macrophage cells were either mock-treated with culture media or infected with 
LCMV-Armstrong (MOI=5) for 1 day. Bone marrow cells were harvested from the femur 
and tibia and cultured in RPMI-1640 media containing 30% L929 supernatant for 6 days; 
the nonadherent cells were removed and the remaining adherent cells, which were >99% 
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F4/80+, were harvested and re-plated in 1x105/well in a 96-well plate as antigen 
presenting cells; the cells were either mock-treated with culture media or infected with 
LCMV-Arm (MOI=5) for 1 day before the addition of responding cells. Spleens from 
LCMV infected mice were harvested at day 8 after the LCMV infection. Single 
splenocyte suspensions were made, and CD8+ T cells were enriched using a CD8a+ T 
cell isolation kit (Miltenyi Biotec), and if necessary, further purified by staining with 
CD8 antibody (53-6.7),  followed by FACS sorting to obtain high purified CD8+ T cells,. 
1x105 enriched CD8+ T cells were added as responding cells to the prepared antigen 
presenting macrophages. The MR1 blocking antibody was added to the antigen 
presenting macrophages at 5 µg/ml 1 hour before the addition of the responding cells. 
The cells were co-cultured for 20 hours, 10µg/ml Brefeldin A was added to the cells for 
additional 4 hours, and the cells were harvested for analysis of IFN! containing cells by 
flow cytometry.  
Results 
Partial clearance of LCMV-Arm virus in the MHC class Ia deficient mice 
CD8 but not CD4 are required for clearance of LCMV, although CD4 is required 
to form CTL memory (29, 30). MHC class II knockout mice can clear the virus as well as 
the wild type mice, but #2-microglobulin is required for the virus clearance (29, 30). To 
investigate the importance of MHC class Ib restricted CD8+ T cells for LCMV clearance, 
Kb-/-Db-/-CIITA-/- mice, which do not express MHC class II and MHC class Ia, were 
infected with the LCMV-Arm, with wild type mice and Kb-/-Db-/-#2m-/- mice as controls. 
All the three types of mice have high virus titer in the spleen at day 3. At day 8, the virus 
was not detectable in the B6 mice, and the titer was consistently lower in the Kb-/-Db-/-
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CIITA-/- mice compared to in the Kb-/-Db-/-#2m-/- mice (Figure 2.1). This suggested that 
MHC class Ib restricted T cells contribute to virus clearance.!!
CD8+ T cells are critical for the partial virus control in the Kb-/-Db-/- mice 
CD8+ T cells are important for control LCMV; in the CD8-/- mice, the infection 
becomes persistent (31). The Kb-/-Db-/-CIITA-/- mice have low amounts of CD8+ T cells 
compared to the wild type mice, and in theory, these CD8+ T cells are restricted by MHC 
class Ib molecules since the mice are deficient in MHC class Ia. To investigate the role of 
CD8+ T cells in the Kb-/-Db-/-CIITA-/- mice during LCMV-Arm infection, the mice were 
inoculated with CD8" antibody (clone 2.43) before and after LCMV-Arm infection. Flow 
cytometry showed that over 95% of the CD8+ T cells in the mice were depleted by the 
antibody treatment (data not shown). With CD8+ T cells depleted, the virus titer in the!
!
 
Figure 2.1 Partial control of LCMV infection in Kb-/-Db-/-CIITA-/- mice. B6, Kb-/-Db-/-
CIITA-/-, Kb-/-Db-/-#2M-/- mice were injected i.p. with 2x105 PFU/mouse LCMV-
Armstrong. Day 3 and day 8 postinfection, virus titers in spleen tissues were measured by 
plaque assay. Three to four mice were included in each group; the data represent one of 


















Kb-/-Db-/-CIITA-/- mice at day 8 after infection was significantly increased to a level as 
high as in the Kb-/-Db-/-#2m-/- mice (Figure 2.2). The virus was also abundant in the CD8+ 
T cell depleted B6 mice spleen, liver, lung and kidney. This proved that CD8+ T cells in  
the Kb-/-Db-/-CIITA-/- mice are critical for the observed partial control of LCMV-Arm 
infection.  
 
CD8+ T cell expansion during LCMV-Arm infection 
Virus specific CD8+ T cells undergo vigorous expansion upon acute LCMV 
infection and the cell percentage and number peaks at 1 week postinfection (32). In both 
the wild type mice and Kb-/-Db-/-CIITA-/- mice, CD8+ T cells expanded after the LCMV-
Arm infection (Figure 2.3A). The percentage and number of CD8+ T cells reaches 
maximum at day 8 in the B6 mice, while the CD8+ T cells continue to expand from day 8 
to at least day 12 in the Kb-/-Db-/-CIITA-/- mice, but Kb-/-Db-/-CIITA-/- CD8+ T cell 
numbers were much lower in number than in the wild type mice (Figure 2.3B). The 
CD8+ T cells in naive Kb-/-Db-/-CIITA-/- mice had a diverse TCR repertoire as shown by 
V# staining (Figure 2.3C). The expanded CD8+ T cells also had a diverse V# repertoire 
and the V# usage was skewed such that the percentage of V#8, V#10, and V#13 positive 
cells was considerably higher than in the uninfected mice. There were very few CD4+ T 
cells in the Kb-/-Db-/-CIITA-/- mice due to the deficiency of MHC class II transactivator 
CIITA, and a considerable percentage of CD4+ T cells in the Kb-/-Db-/-CIITA-/- mice were 
CD1d restricted NK1.1+ NKT cells (data not shown). The CD4+ cell number decreased 
after the infection (Figure 2.3D), probably representing the apoptotic depletion of NKT 
cells after acute viral infections (33, 34). The CD8+ T cells were selectively expanded in 




!.12345!787 Control of LCMV-Arm infection in B6 and Kb-/-Db-/-CIITA-/- mice is 
dependent on CD8+ cells. B6, Kb-/-Db-/-CIITA-/-, and Kb-/-Db-/-#2M-/- mice were either 
mock treated or i.p. inoculated with CD8-specific antibody (clone 2.43) at day -3, -2, -1 
and day 6 of LCMV-Arm infection to deplete the CD8+ T cells. Spleen, liver, kidney, 














































































































































.12345!789!CD8+ T cells in Kb-/-Db-/-CIITA-/- mice undergo expansion after LCMV 
infection. B6 and Kb-/-Db-/-CIITA-/- mice were inoculated i.p. with 2x105 PFU/mouse 
LCMV-Armstrong. At day 3, 5, 8, 12 postinfection, splenocytes were harvested for flow 
cytometry analysis and enumeration. (A) Representative flow cytometry of CD4+ and 
CD8+ cells in spleens from naïve and day 8 LMCV infected mice. (B) The percentage 
and absolute number of CD8+ cells in LCMV-Arm infected mice at different days 
postinfection were analyzed. (C) TCR V" usage in splenic CD8+ T cells from naïve and 
8 day LCMV infected Kb-/-Db-/-CIITA-/- mice was determined by flow cytometry. (D) The 
absolute number of CD4+ cells in the LCMV-Arm infected mice spleen at different days 
post infection as determined by flow cytometry. These results are representative of at 
least two independent experiments.!












































































CD8+ T cells effector phenotype 
CD8+ T cells in the Kb-/-Db-/-CIITA-/- mice undergo homeostatic expansion and 
acquire activation phenotypes in the naïve mice, such that the cells express high levels of 
CD44, CD122, Ly6C and low levels of #7 integrin (8). This makes it impossible to study 
the infection induced CD8+ T cell activation using these markers. The effector 
phenotypes of CD8+ T cells were investigated by examining the presence of Granzyme B 
and IFN!. Wild type and Kb-/-Db-/-CIITA-/- CD8+ T cells did not produce Granzyme B in 
the naïve state and increased Granzyme B production was observed after LCMV 
infection. At day 5 and day 8 after the infection, about 50% of the CD8+ T cells became 
Granzyme B+, indicating that CD8+ T cells in both B6 and Kb-/-Db-/-CIITA-/- mice were 
activated to clear the virus infection (Figure 2.4A). Noticeably, the mean fluorescence of 
the Kb-/-Db-/-CIITA-/- mice CD8+ T cells were higher than that of the B6 cells at day 3, 8 
and 12 (Figure 2.4B). IFN! production was examined by direct ex vivo staining 
splenocytes from the infected mice. Both B6 and Kb-/-Db-/-CIITA-/- CD8+ cells increase 
IFN! production after the infection (Figure 2.5A). The percentage of IFN!+CD8+ cells 
peaked at day 5 and the number reached peak at day 8 in the wild type mice. The 
percentage and number of IFN!+CD8+ cells peaked at day 8 and remained high at day 12 
after infection in the Kb-/-Db-/-CIITA-/- mice. Although naive Kb-/-Db-/-CIITA-/- mice had 
much fewer CD8+ T cells than naïve wild type mice, there were higher percentage and 
number of IFN!+CD8+ cells in the LCMV-infected Kb-/-Db-/-CIITA-/- mice than in the 
infected B6 mice (Figure 2.5B). The results indicated that MHC class Ib restricted CD8+ 
T cells could respond vigorously to the virus infection by producing granzyme B factors 




Figure 2.4 Early and robust LCMV-specific granzyme B production by CD8 T cells 
during LCMV infection in Kb-/-Db-/-CIITA-/- mice. Splenocytes from LCMV-infected B6, 
and Kb-/-Db-/-CIITA-/- mice were stained on the surface for CD8" and TCR", then 
intracellularly for granzyme B and analyzed by flow cytometry. (A) The percentage of 
granzyme B producing-CD8"+TCR#+ splenocytes from B6 and Kb-/-Db-/-CIITA-/- mice at 
day 3, 5, 8 and 12 post LCMV-Arm infection. (B) The mean fluorescence intensity (MFI) 
of granzyme B expression on the CD8#+TCR"+ cells at day 3, 5, 8 and 12 postinfection. 
















































































































.12345!78:!Substantial ex vivo IFN! production by CD8+ cells from LCMV-infected 
mice.  (A) B6 and Kb-/-Db-/-CIITA-/- mice were infected with 2 x 105 PFUs LCMV-
Armstrong and, at days 3, 5, 8, and 12, spleens were harvested and analyzed for surface 
CD8# and intracellular IFN$ by flow cytometry. (B) The percentage and total number of 
IFN$ producing CD8"+ spleen lymphocytes was determined for B6, and Kb-/-Db-/-CIITA-/- 
mice at various time points postinfection.


























































MHC class Ib restricted anti-viral CD8+ T cell response 
Although Kb-/-Db-/-CIITA-/- CD8+ T cell produced IFN! and granzyme B in vivo 
after LCMV-Arm infection, it was not known whether the response was specifically 
induced by the MHC/Antigen/TCR interactions. Memory phase CD8+ T cells might be 
activated nonspecifically to produce IFN! and granzyme B by IL-15 cytokine without 
TCR signaling (35).  The naïve Kb-/-Db-/-CIITA-/- CD8+ T cells show memory 
phenotypes. To exclude the possibility that CD8+ T cells in the infected Kb-/-Db-/-CIITA-/- 
mice were activated by some bystander mechanism, in vitro culture assays were 
established. The initial experiments showed that B6 CD8+ T cells produced IFN! 
detectable by ELISA and flow cytometry when they are co-cultured with LCMV infected 
macrophages for 6 hours, but the Kb-/-Db-/-CIITA-/- CD8+ cells did not produce IFN! after 
6 hours of co-culture with the virus infected macrophages (data not shown). After 
carefully examining multiple experiment parameters, it was found that only when the 
coculture time was elongated, could the Kb-/-Db-/-CIITA-/- CD8+ T cells produce IFN! 
cytokines. The primed CD8+ T cells were restimulated with the virus-infected 
macrophages for 24 hours and the IFN! production was examined by intracellular 
staining (Figure 2.6A). Primed B6 CD8+ T cells could respond to the virus infected B6 
macrophages, but not the uninfected macrophages or the infected Kb-/-Db-/-CIITA-/- and 
Kb-/-Db-/-#2m-/- macrophages, suggesting that majority of the CD8+ T cells from the B6 
mice were restricted by the classical MHC class I molecules. The Kb-/-Db-/-CIITA-/- CD8+ 
T cells could respond to both LCMV infected B6 and Kb-/-Db-/-CIITA-/- macrophages but 
not Kb-/-Db-/-#2m-/- macrophages, suggesting that the CD8+ T cells are restricted by #2m-
bearing MHC class Ib molecules that were expressed on B6 and Kb-/-Db-/-CIITA-/- APCs 
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but not on Kb-/-Db-/-#2m-/- APCs. The LCMV infection activated a population of Ag-
specific, #2m-dependent CD8+ T cells in the mice that lack the expression of MHC class 
Ia and MHC class II. 
To further study which MHC class Ib molecule restricted CD8+ T cell anti-
LCMV response in the Kb-/-Db-/-CIITA-/- mice, bone-marrow derived macrophages from 
single MHC class Ib knockout mice and MHC class Ib blocking antibodies were used in 
the in vitro restimulation assay. Qa-1b-/-, B6.K1(Qa-2-/-), H2-M3-/-, CD1d-/- macrophages 
were used and anti-MR1 blocking antibody (clone 26.5) was used in the assay (Figure 
2.6B and Figure 2.6C). Although Kb-/-Db-/-CIITA-/- CD8+ T cells responded weaker when 
re-stimulated by Qa-2-/- macrophages, no full-reduced IFN! response was detected. This 
indicated that the MHC class Ib restricted anti-LCMV CD8+ T cell response might be 
restricted by multiple elements or by some yet to-be defined unknown MHC class Ib 
molecule.  
 
Kb-/-Db-/- mice response to the LCMV-Arm infection 
Kb-/-Db-/-CIITA-/- mice do not have normal CD4+ T cells, this raises the possibility 
that CD8+ T cell response in the Kb-/-Db-/-CIITA-/- mice were not fully competent due to 
the lack of CD4 + T cell help. Kb-/-Db-/- mice, which do have CD4+ T cells, were also 
infected with the LCMV-Arm virus to examine the CD8+ T cell responses in the 
presence of helper T cells. Kb-/-Db-/- CD8+ T cells expanded upon LCMV infection in a 
similar manner to the cells in Kb-/-Db-/-CIITA-/- mice, that the percentage of CD8+ 




Figure 2.6 MHC class Ib-restricted CD8+ T cells from LCMV-infected Kb-/-Db-/-CIITA-/- 
mice. (A) Peritoneal macrophages were harvested from ConA inoculated B6, Kb-/-Db-/-
CIITA-/-, or Kb-/-Db-/-"2M-/- mice as a source of antigen presenting cells (APCs). APCs 
were either uninfected or infected with LCMV-Arm for 1 day. At day 8 post LCMV-
infection, splenocytes were harvested from B6 or Kb-/-Db-/-CIITA-/- mice and CD8+ T 
cells were enriched and co-cultured with APC for 1 day, followed by analysis of IFN$ 
production by flow cytometry. Left: Representative flow cytometry plots showing the 
production of IFN$ by cultured CD8+ T cells. Right: The percentage of IFN$+ CD8+ T 
















































Kb-/-Db-/-CIITA-/- CD8+ T cells!B6 CD8+ T cells!





































Figure 2.6 continued (B) B6, Kb-/-Db-/-CIITA-/-, Kb-/-Db-/-#2m-/-, Qa-1-/-, B6.K1(Qa2-/-), and 
CD1d-/- bone marrow-derived macrophages were used as APCs. CD8+ T cells enriched 
from day 8 infected mice were co-cultured with the LCMV uninfected or infected APCs 
for 1 day, and the production of IFN$ was measure by flow cytometry. (C) B6, Kb-/-Db-/-
CIITA-/-, Kb-/-Db-/-#2m-/-, and H2-M3-/- bone marrow-derived macrophages were used as 
APCs. MR1 blocking antibody was added as indicated to the B6 or the Kb-/-Db-/-CIITA-/- 
APCs in 5µg/ml to block the MR1 molecule. CD8+ T cells enriched from day 8 infected 
mice were co-cultured with the LCMV uninfected or infected APCs for 1 day, and the 

















































































































































































during the infection (Figure 2.7A). Although the CD8+ T cell number was low, large 
numbers of the cells produced IFN! after the infection and the percentage of 
IFN!+ CD8+ T cells was higher than B6 mice at all measured time points. The IFN!+ 
CD8+ T cell number in the Kb-/-Db-/- mice was comparable to that in the B6 mice at the 
first week post infection, and the number remained high to at least day 12 postinfection 
(Figure 2.7B). The CD8+ T cells from day 8 infected Kb-/-Db-/- mouse responded to 
syngeneic LCMV infected macrophages, but not to Kb-/-Db-/-#2m-/- macrophages, proving 
the CD8+ T cell response was MHC class Ib restricted (Figure 2.7C). 
 
Chronic viral infection in the Class Ia deficient mice  
LCMV-Arm infection usually induces acute infection in the wild type mice and 
the virus is cleared after about 1 week (23). In the early LCMV infection phase, Kb-/-Db-/-
CIITA-/- mice partially cleared the virus as shown by the lower virus titer at day 8 post 
infection, but the virus was not completely gone. To study whether the virus was fully 
cleared in the Kb-/-Db-/-CIITA-/- mice, long-term infection experiment was performed. The 
result showed that the virus was completely cleared in the B6 mice at early phase of the 
infection. The virus titer was low at day 8 and 13 postinfection in the Kb-/-Db-/-CIITA-/- 
mice, but the virus titer was high at day 37 and 82 postinfection (Figure 2.8A). The wild 
type CD8+ T cells expanded at the beginning of the infection and contracted to normal 
level after 2 months. The CD8+ T cells in the Kb-/-Db-/-CIITA-/- mice also expands at the 
beginning, but the percentage and number decreased continuously; at day 82 post 
infection, the CD8+ T cell percentage and number were much lower than normal level 




.12345!78;!Class Ib-restricted T cells are induced in LCMV-Arm infected Kb-/-Db-/- mice.  
(A) B6 and Kb-/-Db-/- CD8+ T cells from day 8 infected mice were restimulated with B6, 
Kb-/-Db-/- or Kb-/-Db-/- #2m-/- bone marrow-derived macrophages which were uninfected or 
infected with LCMV. (B) The percentage and number of spleen CD8+ T cells in naïve 
and day 3, 5, 8, 12 LCMV-Arm infected B6, Kb-/-Db-/- and Kb-/-Db-/-CIITA-/- mice. (C) The 
IFN$+ CD8+ T cell percentage and number in the naïve, day 3, 5, 8, 12 LCMV-Arm 





































































































































during the observed time frame (Figure 2.8C). These results indicated that the low-
numbered CD8+ T cells in the Kb-/-Db-/-CIITA-/- were activated to control the infection, 
but the virus replication may over-counter the CD8+ T cell number, that the CD8+ T cell 
could not fully clear the virus infection and the infection becomes chronic (36). As the 
infection went on, large numbers of the Kb-/-Db-/-CIITA-/- CD8+ T cells die from 
activation-induced cell death and even the remaining live CD8+ T cells become 
exhausted that in the in vitro assay, the CD8+ T cells could not respond to LCMV-
infected syngeneic macrophages any more (Figure 2.8D).    
 
Discussion 
In this project, MHC class Ia deficient mice were studied for their immune 
responses against viral infections. The Kb-/-Db-/- mice on C57BL/6 background do not 
express MHC class Ia molecules, thus do not have MHC class Ia restricted CD8+ T cells. 
The MHC class Ib restricted CD8+ T cells represent a small faction of CD8+ T cells in 
the wild type mice and it is difficult to study their immune functions in the wild type 
mice. The Kb-/-Db-/- mice have much fewer CD8+ T cells compared to the wild type 
animal, but majority of the CD8+ T cells should be restricted by MHC class Ib, providing 
a potential good model for studying the MHC class Ib restricted CD8+ T cell responses 
(6). The Kb-/-Db-/- mice were crossed to CIITA-/- mice to generate mice that are deficient 
in both MHC class Ia and MHC class II. The mice have very few CD4+ T cells and 
CD8+ T cells in the peripheral, but the CD8+ T cell number was significantly increased 
compared to Kb-/-Db-/- mice, which was caused by the homeostatic expansion (8). The T 
cells in the Kb-/-Db-/-CIITA-/- mice also show activated phenotype. Both Kb-/-Db-/- and  
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 .12345!78<!Long-term infection. Groups of B6 and Kb-/-Db-/-CIITA-/- mice were infected 
with 2x105 PFU LCMV-Arm. At day 3, 8, 13, 37, 82 postinfection, a minimum of three 
mice of each strain were characterized to determine the virus titer in the spleen tissue, and 
the CD8+ T cell expansion and INF! production were determined. (A) Virus in spleen 
was measured by plaque assay. (B) The kinetics of spleen CD8+ T cell expansion and 
contraction. (C) The kinetics of ex vivo IFN! production by CD8+ T cells. (D) In vitro 
restimulation of CD8+ T cells from day 49 infected mice. The CD8+ T cells from day 49 
infected mice were co-cultured with infected or uninfected B6, Kb-/-Db-/-CIITA-/-, Kb-/-Db-/-
"2m-/-bone marrow-derived macrophages for 1 day, and the IFN$ production was 














































































































































Kb-/-Db-/-CIITA-/- mice were used in the study. In response to the infection, the CD8+ T 
cells proliferated, secreted IFN! and granzyme B in vivo. The virus infection was 
partially but not fully controlled during the first 2 weeks of the infection, and in long-
term, the infection became chronic in the MHC class Ia deficient mice. The partial 
control relied on the CD8+ T cells that in the CD8+ T cell depleted mice, the infection 
totally lost control. The in vitro restimulation assay proved that the Kb-/-Db-/- and Kb-/-Db-/-
CIITA-/- CD8+ T cell anti-LCMV response was dependent on #2m but independent of 
MHC class Ia molecule Kb or Db, suggesting the reaction was restricted by #2m-bearing 
MHC class Ib molecules. The Kb-/-Db-/-CIITA-/- mice were not able to fully clear the virus 
infection. As the infection went on, the CD8+ T cell percentage and number dropped 
continuously. The CD8+ T cells in the naïve Kb-/-Db-/-CIITA-/- mice had proliferated by 
homeostatic expansion, that they might easily become exhausted upon infection induced 
activation and proliferation (37, 38); many cells might die as the infection became 
chronic; the remaining live cells gradually lost their ability to produce IFN! cytokines as 
shown by the in vitro restimulation assay at later time point postinfection. 
MHC class Ib restricted T cell response were found during bacteria infections. 
The H2-M3 participated in the immune response against Listeria monocytogenes and 
Mycobacteria tuberculosis (3, 14, 39-41). Kb-/-Db-/- mice could protect the mice from 
Listeria infection as efficient as the wild type mice, suggesting the MHC class Ib 
restricted CD8+ T cells were potent to kill the Listeria infected target cells and to restrain 
the spread of the virus infection (40). Qa-1b also participated in anti-bacterial response 
that a group of CTLs specifically react to Salmonella GroEL peptides presented by Qa-1b 
(12, 13). There was very few research studying the participation of MHC class Ib 
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molecules in anti-viral response. Kb-/-Db-/- mice control !-herpes virus 68 infections to 
the same level as B6 mice, but the restriction element of the CD8+ T cells was not clear 
(18). The CD8+ T cells expanded and produced cytokines, and the number of 
unconventional CD8+ T cells in Kb-/-Db-/- mice at day 42 postinfection was comparable to 
the CD8+ T cells number in the B6 mice (18). In our experiment, after the LCMV 
infection, the unconventional CD8+ T cells expanded and gradually contracted to a level 
lower than in naïve mice and lost their ability to produce IFN! cytokine. These suggested 
that the virus type and infection pattern influenced the unconventional CD8+ T cell 
response. It could be that unconventional CD8+ T cells were capable to control the 
herpes virus infection at the acute phase and when the herpes infection became latent, 
there were very few herpes antigens to stimulate CD8+ T cell response that the CD8+ T 
cell turnover rate became slow and the cells could survive for long time. While during 
LCMV-Arm infection, the virus expanded continuously, and in response, the CD8+ T 
cells in the MHC class Ia deficient mice also expanded cycle after cycle to keep in pace 
with the virus expansion and tried to clear the virus; eventually, the cells expanded too 
many cycles that they became exhausted and many of the cells die by apoptosis and even 
the live cells gradually lost their ability to control virus infection (42). The LCMV virus 
replication in the MHC class Ia knockout mice might overwhelm the few-numbered 
CD8+ T cell response that the infection became chronic (36). MHC class Ib restricted 
anti-viral response was clearly demonstrated in a polyoma virus infection mouse model, 
in which H2-Q9 was identified as the restriction element for a polyoma virus VP2 peptide 
(17). Our study on the LCMV virus extended the knowledge on MHC class Ib restricted 
anti-viral response. Although the MHC class Ia deficient mice were not able to fully clear 
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the virus, the CD8+ T cells clearly showed MHC class Ib restricted anti-LCMV 
response. The lack of clearance might be due to the low CD8+ number in the MHC class 
Ia deficient mice. The CD8+ T cells in these mice had undergone homeostatic expansion, 
and that might lead to the early exhaustion of the T cells. The well-known individual 
MHC class Ib molecules, Qa-1, Qa-2, H2-M3, CD1d, MR1, were tested in the in vitro 
restimulation assay. Qa-2 seems to restrict a small part of the CD8+ T cell response, but 
the response was not fully diminished when the CD8+ T cells were stimulated with Qa-2-
/- APCs. The response might be restricted by multiple MHC class Ib elements or 
restricted by an unknown MHC class Ib. 
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H2-T11, A FUNCTIONAL PARALOG OF H2-T23 
Abstract 
H2-T11 is a gene with high similarity to the Qa-1b encoding gene, H2-T23. 
Hybrid H2-T11 and H2-T23 expressing H2-Db "3 domain were used to study the 
properties of H2-T11. H2-T11 was transcribed in multiple organs in mice and the hybrid 
molecule could be expressed at comparable level to H2-T23 on Hela and T2 cell surfaces. 
In vitro folding experiments showed that T11 can fold with or without Qdm peptide, and 
the folded T11 had a typical MHC circular dichroism spectrum. T11 were able to bind 
Qdm peptides, but the complex was not stable at 37°C. Functional studies showed that 
T11 does not have the same functions as T23. T11 cannot present an insulin peptide to a 
T23 (Qa-1b)-restricted T cell hybridoma (6C5) and it does not interact with NK 
receptors. Peptide elution from molecules isolated from Hela cells expressing hybrid T11 
or T23 showed that although Qdm was the dominant peptide bound to T23, there were 
still many other peptides eluted from T23. Multiple peptides were also eluted from T11, 
including Qdm, but Qdm was not abundant in the T11 peptide pool.  
 
Introduction 
MHC class Ib molecules are nonclassical MHC molecules that share similar 
structure to the classical MHC class I, but have more restricted tissue distribution and 
lower expression levels. The majority of MHC class Ib molecules are encoded at the 
 !
56 
telomeric end of MHC region. In the mouse, that region is divided into three parts, H2-
Q, T, and M (1, 2). There are about 40 MHC class Ib genes encoded in the mouse, and 
about 20 of them were transcribed (3). Only a few of the MHC class Ib molecules have 
been studied, and many of them remain to be characterized. The well-studied MHC class 
Ib molecules have special functions that are distinct from classical MHC. CD1d 
molecules present lipid antigens to the TCRs of natural killer cells bearing invariant V# 
chains (4-7). H2-M3 has selective preference for N-formylated peptides that are encoded 
in the prokaryotic organisms and in mitochondria of eukaryotic cells (8-12). Qa-1b 
predominantly binds Qdm peptides generated from the leader sequence of other MHC 
class I molecules, and presents them to the CD94/NKG2 receptors of NK cells and NKT 
cells; the signal initiated by the Qa-1b/Qdm/NKG2A interaction inhibits the activation of 
the NK cells and NKT cells; the decoding of Qa-1b/Qdm/NKG2A interaction provides 
one of the molecular mechanisms for the NK cell “missing-self” theory (13-18).  
Qa-1b is encoded by H2-T23 gene in the mouse MHC T region. The gene is 
ubiquitously transcribed, but the Qa-1b protein surface expression level is lower 
compared to the classical MHC class I molecules, which are also expressed on almost all 
the nucleated cells (3). In the mouse T region, there are several other genes encoded, 
which may have derived from gene duplication and mutation. The phylogenetic tree 
analysis showed that H2-T11 is very close to H2-T23 evolutionarily (19). These genes 
may have duplicated recently. By alignment of the potential cDNA, the nucleotides are 
over 95% identical between T11 and T23 in B6 mice; the amino acids of the putative 
proteins were 91% identical. We hypothesized that H2-T11 might encode proteins with 
functions similar to Qa-1b. Because there is no antibody available to recognize H2-T11, 
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the H2-T11 "3 domain was replaced with an antibody-recognizable H2-Db "3 domain, 
and the peptide binding "1 and "2 domain were retained (20). As a control, an H2-T23 
hybrid molecule was generated in the same way. The expression, biochemical properties, 
and peptide binding functions of H2-T11 were studied in this project. 
 
Materials and methods 
Mice 
C57BL/6 mice were purchased from Jackson Laboratories. Qa-1b-/- mice were gift 
from Dr. Harvey Cantor (Harvard Medical School) (21). All the mice were maintained in 
the University of Utah specific pathogen-free animal facility and used according to the 
Institutional Animal Care and Use Committee policies. 
 
Gene expression analysis 
H2-T11 cDNA sequence was provided by Dr. Attila Kumanovics (University of 
Utah). H2-T23 cDNA sequence was from NCBI database (GI: 111074554). The H2-T11 
cDNA sequence was aligned to H2-T23/Qa-1b by BLAST. The putative T11 protein 
sequence was translated by ApE application and aligned to Qa-1b.  
The primers used for amplifying H2-T11 and H2-T23 from mouse genome and 
total RNA were as follows: T11 forward, CGGTATTTCCACACCGTCGTA; T11 
reverse, TAGAGATATGCGAGGCTAAGTTG; T23 forward, 
AGTATTGGGAGCGGGAGACTT; T23 reverse: AGCACCTCAGGGTGACTTCAT 
(19). The polymerase was Taq (Invitrogen). PCR reaction was done as regular on a TC-
4000 machine (Techne).  
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Murine RNA polymerase 2A (POLR2A) was used as the reference gene for 
T11 during quantitative-PCR (Q-PCR). The primers for Q-PCR were: T11 forward, 
TAAACCTGAGGACCCTGCTC; T11 reverse, TAGGCCTCCTGACAATACCC; 
POLR2A forward, /)"))))"%//"%""%"%/"=!*#,+7)!45>54?5@!/"%%/"""%"%)")%%"%/"8 The mouse tissues were stored in RNAlater solution 
(Ambion) for less than a week at 4°C before RNA was extracted. The total RNA was 
extracted by RNeasy mini kit (Qiagen). The cDNA was synthesized by QuantiTect 
Reverse Transcription kit (Qiagen). The quantitative-PCR kit was Absolute QPCR SYBR 




The "3 domain of H2-T11 and H2-T23 was replaced with the "3 domain of H2-
Db cDNA, and the hybrid molecules were named as H2-T11D3 and H2-T23D3, 
respectively. The H2-T11D3 and H2-T23D3 cDNA were synthesized (Biomatik). The 
synthesized cDNA were sequenced to verify the sequences before being cloned to 
expression vectors. The cDNAs were cloned into mammalian expression retroviral vector 
MigR1 (22) and bacteria expression vector pTCF (NIH tetramer core facility), and the 
cloning products were verified by restriction enzyme digestion and sequencing. All the 
restriction enzymes were from NEB laboratories. GoTaq (Promega) was used for PCR. 
The plasmids were purified by Plasmid Mini kit (Qiagen) for general testing and cloning, 






Phoenix, Hela and T2 cells were cultured in DMEM complete media 
supplemented with 10% FBS, 100 U/ml penicillin, 100 mg/ml streptomycin, 292 mg/ml 
L-glutamine, 100 mM nonessential amino acids, 1 mM sodium pyruvate, and 55 mM 2-
mercaptoethanol (Invitrogen). The primary mouse cells were cultured in RPMI-1640 
complete media supplemented the same way as DMEM media. All the cells were 
maintained at 37°C humidified cell culture incubator containing 5% CO2. 
 
Retroviral transduction 
Phoenix-GP cells were added at 4x106 cells/dish to a 6 cm collagen I coated cell 
culture dish (BD). Eighteen hours later, 10 µg MigR1 vector containing the H2-T11D3 
cDNA or H2-T23D3 cDNA was co-transfected with 5 µg Env plasmid to the phoenix 
cells by calcium-phosphate precipitation. Two days later, the supernatant containing the 
packaged retrovirus was harvested and passed through 0.45 µl sterile filter for 
transduction. Half ml of 1x106/ml Hela or T2 cells were mixed with 0.5 ml of the 
retroviral supernatant in the presence of 5 µg/ml polybrene (sigma), and the cells were 
distributed evenly on collagen-I coated 6 cm plates (BD). Four hours later, 4 ml fresh 
media were added. After at least 3 days, the cells were harvested and the target gene 
expression was examined by flow cytometry. The cells were sorted at least twice by 
EGFP expression level to get cells stably expressing high levels of target genes. 
 
Expression of recombinant protein 
The pTCF vector containing the T11D3 or T23D3 genes were transduced to 
BL21(DE3) E.coli (Invitrogen). Target gene positive clones were tested for producing 
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recombinant proteins before they were expanded in 2L Luria Broth media. 1mM IPTG 
was added to the culture when the OD600 reached ~0.6. The bacteria were harvested 4 
hours later. The bacteria was pelleted by centrifugation, resuspended in resuspension 
buffer (50 mM pH 8.0 Tris-HCl, 25% (W/V) sucrose, 1 mM EDTA, 0.1% (w/v) NaAzide, 
10 mM DTT) and stored in -80°C. The frozen bacteria were thawed and 1mg/ml 
lysozyme, 5mM MgCl2, 33 µg/ml DNaseI, 3.3% (V/V) Triton-X, and 10mM DTT were 
added to the bacteria. The bacteria were stirred and lysed at room temperature for 1 hour 
before being sonicated. The inclusion body was washed multiple times with wash buffer 
(50 mM pH8.0 Tris-HCl, 0.5% Triton-X100, 100 mM NaCl, 1 mM EDTA, 0.1% 
NaAzide, 1mM DTT) until the protein pellet was white and the supernatant was clear. 
The pellet was washed one more time with the wash buffer without DTT. The 
recombinant inclusion body was solubilized in 6M guanidine chloride and was aliquoted 
and stored at -80°C until use.     
 
In vitro MHC class I folding 
Soluble T11D3 and T23D3 recombinant proteins were folded in vitro as before 
(23). Briefly, T11D3 or T23D3 heavy chain inclusion body together with 6 mg human 
#2-microglobulin (#2m) light chain was diluted in 100 mM Tris folding buffer (pH 8.0) 
containing 400 mM L-arginine, 2 mM EDTA, 0.5 mM oxidized glutathione, 5 mM 
reduced glutathione, 0.2 mM PMSF in the absence or presence of Qdm peptides. The 
gram ratio of heavy chain : light chain : peptide was 3 : 1 : 1. The folding reaction was 
kept in 10°C for 2 days before it was harvested and concentrated by the Amicon 
ultrafiltration cell (Millipore). The concentrated sample was filtered through 0.45 µm 
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filter and purified by S300 gel filtration column. The purified folding product was 
concentrated by Amicon Ultra centrifugal filters (Millipore), buffer exchanged to PBS 
and stored at -80°C.  
 
Gel electrophoresis 
All the DNA products were examined using 1% or 2% agarose gel. The 
recombinant inclusion body was examined using 12% SDS-polyacrylamide gel. The 
MHC folding products were examined using 4%-20% gradient Tris–HCl gel (Bio-rad). 
 
Antigen presentation assay 
Hela transfectant cells (5x104) or B6 splenocytes (1x106) were used as antigen 
presenting cells, and co-cultured with 1x105 6C5 T cell hybridoma responding cells (24) 
overnight in the presence of different doses of bovine insulin (Sigma) in 96-well plates. 
The supernatant was harvested, and the production of IL-2 was measured by Europium-
based immunoassay (25). 
 
Eu-based peptide binding assay 
The peptide binding was examined by Europium-based immune assay (25). 
Briefly, 96-well ELISA plate (greiner Microlon) was coated with 50µl 5µg/ml anti human 
#2m antibody (clone BB7.7) at 37°C for 2 hours; the plate was blocked by 200µl MTB (5% 
powdered skim milk, 1% BSA, 0.01% NaAzide in TTBS) for 30 minutes at room 
temperature; 1µg folded MHC monomers were diluted in 100 µl MTBN and incubated in 
the antibody coated plate for >2 hours at 4°C; the biotin-labeled peptides were diluted in 
0.01% NP-40 substitute (Fluka) in PBS and incubated in the plate overnight at room 
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temperature; the plate was developed by the Europium reagent and the fluorescence 
signal was recorded by Victor3V plate reader (Perkin Elmer); the plate was washed 
extensively by the TTBS buffer (50 mM Tris, 150 mM NaCl, 0.1% Tween-20, pH7.5) 
before the addition of a new reagent.   
 
Fluorescence polarization assay 
Folded MHC monomers were incubated with Alexa Fluro488-labeled Qdm4C 
peptides in Citrate/PO4 buffer (200 mM citric acid, 200 mM Na2HPO4, pH7). The parallel 
and perpendicular fluorescence signals ( III !6AB! I! ) were recorded at 60 seconds 
intervals for total 60000 seconds by Infinite F200 microplate reader (Tecan) at 37°C or 
25°C. Pure MHC monomer, AF488-labeled peptide, or buffer were also detected 
independently to record the background signal. After the background signals were 




Circular Dichroism assay 
The CD spectrum was measured by AVIV 410 CD instrument (AVIV Biomedical 
Inc.). The folded MHC monomer concentration was determined by OD280 and was 
diluted to 250 µg/ml in PBS. The far-UV CD spectrum was recorded in a cuvette with 
1mm path-length at 25°C. The sample was scanned from 200 nm to 260 nm with a step 
of 1nm. The averaging time was 3 seconds and every step was scanned three times. The 
PBS background data were recorded in the same cuvette and was subtracted from all the 
sample data.   
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The thermal stability of the folded MHC was studied by detecting the CD 
signal at 222 nm. The temperature was increased by a step of 2°C from 25°C to 79°C. At 
each temperature point, the sample was equilibrated for 30 seconds before collecting the 
data. The averaging time was 30 seconds.  
 
MHC class I tetramer 
MHC tetramer was prepared as described before (27). S300 purified MHC 
monomer was buffer exchanged to 10 mM Tris buffer (pH8.0) and concentrated to 2 
mg/ml. 1 mg of the MHC monomer (8/10 volumes) was mixed with 1/10 volume 
10xBiomixA, 1/10 volume of 10xBiomixB and 5 µg BirA enzyme (GeneCopoeia). The 
reaction was kept at room temperature overnight. The product was further purified by 
MonoQ anion exchange column. The biotinylated MHC monomer was tetramerized by 
gradually adding 1/10 of the total required APC-labeled streptavidin to the sample and 
incubating at room temperature for 10 minutes after each addition, so that each 
streptavidin was saturated and the final ratio of biontinylated MHC to streptavidin was 
4:1. The biotinylated MHC was snap-frozen and stored at -80°C. The tetramer was stored 
at 4°C and used within 6 months.  
 
Abs and flow cytometry 
FITC labeled anti-mouse CD3&, PerCP-Cy5.5 labeled anti-mouse B220, PE 
labeled anti-mouse NKp46, PE-Cy7 labeled anti-mouse NK1.1 antibodies were 
purchased from eBioscience and Biolegend. The staining was done in a buffer composed 
of PBS, 0.5% BSA, and 2 mM EDTA. The suspended cells were incubated with the 
antibodies and the tetramer for 20 minutes at 4°C. The stained cells were washed twice 
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with the buffer and fixed with 1% paraformaldehyde. The fluorescence was detected 
on a FACS Canto II machine (BD Biosciences). The data was analyzed by Flowjo 
application (Tree Star).  
 
Peptide elution and identification 
The T11D3 and T23D3 bound peptides were eluted as described before (28). 
Hela-MigR1, Hela-T11D3 and Hela-T23D3 cells were cultured in T150 cell culture 
flasks. Each cell type was cultured in 20~25 flasks and harvested when they were 80% to 
90% confluent so that the total cell collected for each cell type was more than 1x109. The 
cells were spin down, washed twice with cold DPBS, and the pellet was stored in -80°C 
for less than 2 months until the next step. The cells were lysed by NP-40 buffer (0.5% 
nonidet P-40, 500 mM pH8.0 Tris-HCl, 150 mM NaCl and protease inhibitors). The 
lysate was centrifuged several times, and the supernatant was passed through a Tris-
blocked Sepharose column to pre-clear the lysate. The hybrid MHC was 
immunoprecipitated by protein A beads cross-linked with 28-14-8s antibody. The beads 
then were washed with four different buffers in sequence: (1) 0.005% Nonidet P-40, 50 
mM Tris-HCl (pH 8.0), 150 mM NaCl, 5 mM EDTA; (2) 50 mM Tris-HCl (pH 8.0), 150 
mM NaCl; (3) 50 mM Tris-HCl (pH 8.0), 450 mM NaCl; (4) 50 mM Tris-HCl (pH 8.0). 
The MHC-peptide complexes were eluted from the beads by 10% acetic acid, lyophilized, 
resuspended in 100 µl DMSO, loaded to HPLC and fractionated by HPLC (Beckman 
Coulter) to 27 fractions. Each fraction was concentrated to ~10 µl before mass 





Transcription of T11 gene in B6 and Qa-1b-/- mice 
H2-T11 and H2-T23 sequences are highly homologous to each other and they 
might be recently duplicated genes (19). Over 95% of the cDNA nucleotides of H2-T11 
match the ones of H2-T23, and 91% amino acids of the putative proteins are identical to 
each other (Figure 3.1A and B). Despite their high similarity, primers were designed to 
distinguish them. The sequence of the T11 primers were: 
CGGTATTTCCACACCGTCGTA and TAGAGATATGCGAGGCTAAGTTG; T23 
primers were: AGTATTGGGAGCGGGAGACTT and 
AGCACCTCAGGGTGACTTCAT (19). Genomic DNA analysis showed both T11 and 
T23 gene were detected in wild type mice, while only T11 was detected in T23 knockout 
mice (Qa-1b-/-) (Figure 3.2A). Reverse-transcriptional PCR showed that T11 is 
transcribed in the two major lympohoid organs, spleen and thymus. The T23 transcript 
was also detected in spleen and thymus as expected (Figure 3.2B). The amplified cDNA 
sequences were 415 bp for T11 and 438 bp for T23, and were sequenced to confirm that 
they were truly T11 and T23 transcripts.  
Quantitative-PCR was performed to study the tissue-specific expression of T11. 
Because of the high similarity of T23 and T11, it was hard to design short quantitative-
PCR primers specifically recognizing T11. The three pairs of Q-PCR primers designed to 
distinguish T11 and T23 failed to amplify any DNA in the preliminary tests (data not 
shown). To circumvent this problem, T11 expression level was studied using Qa-1b-/- 
mouse tissue RNA instead of wild type mouse RNA. The T23 exon 1, 2 and 3 are deleted 




Figure 3.1 Alignment of H2-T11 putative protein sequence to H2-T23/Qa-1b sequence. 
(A) Blast of H2-T11 sequence to H2-T23 sequence. "+" indicates conserved 
substitutions. (B) Alignment of H2-T11 to the structure of Qa-1b/Qdm. Green color is 
MHC heavy chain; cyan colar is #2m; yellow color is the peptide. Megenta color 


















preliminary testing, a pair of primers flanking T11 exon 2 and 3 was used in the 
quantitative-PCR assay. The T11 amplicon size was 127 bp. Murine RNA polymerase 2A 
(POLR2A) was used as the reference gene (29). The Q-PCR result showed that T11 was 
expressed at relatively high level in spleen, thymus and intestine, but at low level at 
kidney, heart and pancreas. The highest T11 expression level was detected in the thymus 
(Figure 3.2C).  
 
Expression of H2-T11 protein on surface of TAP+/+ and TAP-/- cells 
Hybrid T11D3 and T23D3 were transduced into Hela and T2 cells using the 
MigR1 retroviral system, which has a EGFP gene connected by IRES to the target gene 
(22). The cells express intrinsic human #2m to form MHC structure with the transduced 
heavy chain. Clone 6A8 (mouse IgG1, ') and 28-14-8s (mouse IgG2a, ') were used to 
detect the surface expression of the transduced genes. 6A8 recognizes the "2 domain of 
Qa-1b, and 28-14-8s targets the hybrid H2-Db "3 domain (Figure 3.3A). The T23D3 was 
recognized by both 6A8 and 28-14-8s antibodies, proving their surface-localized 
expression (Figure 3.3B). Although 6A8 was generated against Qa-1b, it might also 
recognize T11D3, suggesting a 6A8 epitope shared by T11 and T23. The recognition of 
T11 by 6A8 antibody was much weaker than T23. Qa-1b has a wide tissue distribution 
that it is expressed in most nucleated cells similar to MHC class Ia molecules, but unlike 
Ia molecules which requires the TAP complex for the cell surface expression, Qa-1b cell 
surface expression occurs in the absence of TAP (17). The T23D3 hybrid molecule was 
detected on the surface of T2 cells, which are TAP deficient. T11D3 was also expressed 




Figure 3.2 Transcription of T11 genes. (A) PCR amplification of T11 and T23 genes 
from the wild type C57BL/6 (B6) mouse and Qa-1b-/- (KO) genomic DNA. The T11 
amplicon size was 628bp and the T23 amplicon size was 677bp. (B) Reverse-
transcriptional PCR amplification of T11 and T23 transcripts from the B6 mouse spleen 
(spl) and thymus (thy). The amplicon sizes are 415 bp and 438 bp for T11 and T23 
respectively. RT: reverse transcriptase. (C) Quantitative-PCR to determine the T11 
transcription level in different tissues. The total RNA was extracted from Qa-1b-/- mice. 
The reference gene was RNA polymerase 2A (POLR2A). The ratio of T11 to POLR2A 
was calculated according to the Pfaffl method. 
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suggesting that TAP was also dispensable for T11 surface expression (Figure 3.3B).  
 
Antigen presentation function 
Our lab found that a small subset of CD8+ T cells responding to insulin was selected by 
Qa-1b in the mouse (24, 30). The CD8+ T cell hybridoma, 6C5, can respond to Qa-1b 
presented bovine insulin by producing IL-2 in a dose-dependent way. T11D3, T23D3 
transduced Hela cells were examined for their ability to present insulin to 6C5 cells. 
Empty vector transduced Hela-MigR1 cells were used as a negative control, and B6 
splenocytes, which containing Qa-1b expressing antigen presenting cells, were used as 
positive control (Figure 3.3C). The antigen presenting cells were co-cultured with the 
6C5 hybridoma in the presence of different doses of bovine insulin. The Eu-based assay 
showed that Hela-T23D3 cells had the best capacity to present insulin to 6C5. Much 
higher IL-2 levels were detected in the supernatant of Hela-T23D3/6C5 cultures than in 
splenocytes/6C5 cultures. By contrast, there was no IL-2 detected in the Hela-
T11D3/6C5 cultures, suggesting that either T11 could not present insulin or insulin 
presented by T11 could not be recognized by the V"3.2-V#5.1/5.2 TCR on 6C5 T cells.   
 
Folding of T11 with or without Qdm peptide in vitro 
Qdm has the ideal sequence for binding to Qa-1b, and it can form a stable 
complex with Qa-1b at 4°C (23). To test whether Qdm can bind to T11, recombinant 
T11D3 and T23D3 were folded with human #2m at 10°C in the presence or absence of 
Qdm peptide, and the folding products were passed through S300 size-exclusion column 




Figure 3.3 Expression of hybrid T11 and T23 molecules and the functional test of hybrid 
molecule expressing cells. (A) Strategy for making the hybrid MHC molecule. The T11 
and T23 "3 domain was replaced with the H2-Db "3 domain, which could be recognized 
by the 28-14-8s antibody. (B) Expression of hybrid T11 and T23 on the surface of Hela 
and T2 cells. Hela cells were stained with 28-14-8s antibody and T2 cells were stained 
with 28-14-8s antibody and 6A8.6F10.1A6 antibody. (C) Antigen presentation assay to 
test the hybrid molecule-expressing cells’ capability to present insulin to 6C5 hybridoma. 
(BINS: bovine insulin)  







































Qdm peptides for folding. In the absence of Qdm, no folding peak was detected 
(Figure 3.4A). In contrast, an apparent folding peak was detected when T11D3 folded 
with #2m in the absence of exogenous peptide ligand, but the peak was consistently 
higher when Qdm was included in the folding reaction (Figure 3.4A). The peaks 
representing the correct folding products were concentrated and examined by SDS-PAGE. 
Both heavy chain and light chain were detected, indicating correct folding (Figure 3.4B). 
The product was also examined by Europium-based fluorescence immunoassay where the 
folding product was captured by anti-#2m antibody (BB7.7) and detected by the 28-14-8s 
or 6A8 antibody. The result showed that folded T11 and T23 products could be 
recognized by both 28-14-8s and 6A8 antibodies, but 6A8 recognized T23 better than 
T11 (Figure 3.4C). The signal for T11D3-#2m was lower than T11D3-#2m-Qdm even 
though the same amount of folding products were added, suggesting that there might be a 
structure change that influenced antibody recognition, or T11D3-#2m was less stable than 
T11D3-#2m-Qdm.  
To confirm that T11D3 and T23D3 did form MHC structures with #2m, circular 
dichroism was used to study secondary structure. The results showed that T11D3-#2m, 
T11D3-#2m-Qdm, T23D3-#2m-Qdm all had typical MHC wavelength spectrums as 
reported in previous studies (Figure 3.5A) (31-34). This included a single peak signal at 
~220nm, which was in conformity with MHC #-sheet dominated structure. Thermal 
stability experiments showed that the folded T11 product had reduced stability compared 
to T23.  MHC proteins lose their regular secondary structure and form random coils at 
increasing temperature, such that molar elipticity gradually approaches zero (31, 32, 35). 




Figure 3.4 In vitro folding of the hybrid T11 and T23 molecules. (A) S300 spectrum of 
the folding products. Arrows indicate the correct folding product peak. Top panel: black 
line, T23D3-#2m folding, gray line, T23D3-#2m-Qdm folding; bottom panel: T11D3-
#2m folding, gray line, T11D3-#2m-Qdm folding. (B) SDS-PAGE of the purified folding 
products. The MHC heavy chain is ~33kD and the light chain is ~14kD. (C) Eu-based 
immunoassay to examine the folding products. Folding MHC monomer was captured by 

























































elipticity, but the denaturation was not complete. It looked like T11 had a transient 
stable structure such that the molar elipticity remained at a level between zero and the 
value characteristic of folded MHC (Figure 3.5B). 
 
The capacity of T11 to bind Qdm peptide 
The peptide binding capability of the folded MHC proteins were tested by using Eu-
based immunoassay. The folded hybrid T23 monomer was observed to bind labeled Qdm 
peptide, as expected, but it did not bind the Kb-specific SIINFEKL peptide. Folded T11 
monomer can also bind Qdm peptide, but only if when Qdm was present in the folding 
reaction; the “empty” T11 monomer was not able to bind Qdm (Figure 3.6A). Direct 
peptide elution from the T11D3-#2m-Qdm folding monomers showed that about half of 
the monomers were folded with the Qdm peptides (data not shown). Exogenous addition 
of Qdm peptide to the folding reaction might help the T11 monomer to form a Qdm 
adaptable structure. The peptide binding was also examined using a fluorescence 
polarization assay. Alexfluor488 labeled Qdm peptide was incubated with the folded 
MHC monomer and the binding signal was detected in real-time. The result showed that 
Qdm binds to T23D3 and Qa-1b monomers with similar association kinetics. However, 
T11 monomer appears to be unstable at 37°C (Figure 3.6B). It had a very fast initial Qdm 
binding kinetics followed by a rapid decay at 37°C. Qdm binding was more stable at 
25°C such that both the binding and the signal decay were slower (Figure 3.6C). 
 
T11-Qdm tetramers do not bind NK receptors 





Figure 3.5 Circular dichroism studies of the in vitro folded MHC monomers. (A) Far-UV 
circular dichroism spectrum of folded MHC. Each figure was the average of three scans, 
and represented one of three independent experiments. (B) Thermal denaturation curves 
were CD signals recorded at 222nm and the temperature was increased at 2°C interval 
from 25°C to 79°C. Each curve was the average of three independent experiments. 
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Figure 3.6 Qdm-binding capability of T11. (A) Eu-based immunoassay to test the ability 
of folded T11 and T23 monomers to bind Qdm peptide. Folded MHC monomers were 
captured on plate and incubated with the biotin-labeled peptides at room temperature 
overnight. (B) and (C) Fluorescence polarization (FP) assay. Folded MHC monomers 
were incubated with Alexfluro488 labeled Qdm peptides and the FP signal was recorded 
























































cells and NKT cells (15, 16, 36). About half of NK1.1+ cells in mice express 
CD94/NKG2 receptors and these cells can be identified by the Qa-1b/Qdm tetramers (14). 
To determine if T11 can also function as a CD94/NKG2 ligand, MHC tetramers were 
generated by biotinylating folded T11D3-#2m-Qdm and T23D3-#2m-Qdm monomers, 
following by tetramerization with APC labeled streptavidin (Figure 3.7A). C57BL/6 
spleen and liver lymphocytes were stained with the tetramer. About half of the natural 
killer cells (CD3-NKp46+) stained positive for T23 tetramer (Figure 3.7B). 24% of the 
CD3+ liver lymphocytes were T23 tetramer positive, representing the natural killer T 
cells, which are abundant in livers (37). Unlike T23 tetramer staining, no cells stained 
significantly positive with T11 tetramer (Figure 3.7B). Lymphocytes from thymus, iLN, 
mLN, payer’s patches and bone marrow were also examined and no T11 tetramer 
positive population was detected. This suggests that T11 is not a ligand for NK receptors. 
It is also possible that Qdm is not the natural peptide ligand for T11, and that a receptor 
may exist that recognizes T11 bound with a yet to be determined peptide.   
 
Peptide elution from Hela cells expressing T11 and T23 hybrid molecules  
T11 and T23 bound peptides were eluted from Hela-T11D3 and Hela-T23D3 cells 
respectively (Table 3.1 and 3.2). The background peptides from Hela-MigR1 were 
subtracted from the eluted peptide pool. Forty-one unique peptides with length of 8 to 12 
amino acids were eluted from T23D3, and 23 unique peptides with length of eight to ten 
amino acids were eluted from T11D3. For all the unique peptides, 30/41 and 19/23 eluted 
from T23D3 and T11D3 were 9mers, respectively (Figure 3.8A). More than half of the 




Figure 3.7 MHC tetramer staining. (A) Streptavidin binding of biotinylated MHC 
monomers. Biotinylated MHC was incubated with or without over-dosed streptavidin for 
1 hour at room temperature, and the samples were examined by SDS-PAGE. (B) B6 
spleen and liver lymphocytes were stained with B cell, T cell, NK cell markers and the 









that Ala is dominant at P2, and the major amino acids in the P9 position are Leu, Val 
and Tyr (Figure 3.8B). Qdm was found in both the T23D3 and T11D3 eluted peptide 
pools, but it was only showed up once in the T11D3 pool, not more frequent than the 
other peptides, whereas Qdm was detected up nine times in the T23D3 pool (data not 
shown), consistent with previous reports that Qdm is the dominant peptide that associates 
with T23 in cells. The peptide elution data suggest that T11 molecules can bind multiple 
peptides including Qdm, with binding motif that overlaps with T23, but that T11 does not 
have the same optimized structure for binding Qdm as does T23. 
 
Discussion 
The H2-T11, an MHC class Ib gene from the mouse MHC H2-T region, encodes an 
MHC protein. Despite the high homology of H2-T11 to H2-T23, unlike the ubiquitously 
expressed T23 gene (3), T11 is transcribed in relatively high level in spleen, thymus, 
intestine, but transcribed at very low level in kidney, heart and pancreas, suggesting that 
after the gene duplication, T11 and T23 evolved independently, and mutations might 
accumulate in their expression regulatory elements after their duplication, leading to 
tissue specific expression patterns (38, 39). T11 was expressed at very high levels in 
thymus, suggesting it might participate in the T cell maturation and that T11-restricted T 
cells might be selected in the thymus. Future investigation will be informed by analysis 
of the expression of T11 in specific cell subpopulations in the thymus.  
Although Qa-1b does not require TAP for surface expression, the binding of Qdm 
to Qa-1b is TAP-dependent (40). In TAP deficient cells, in the absence of the high 
affinity Qdm peptide, the Qa-1b binding groove was reported to be occupied by various 
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Table 3.1 Peptides eluted from Hela-T11D3 cells 
 
MHC! Sequence! Peptide Length! Peptide Origination!
T11! NIFRNVEV! 8! Ras-related GTP-binding protein A!
 ! AAFDKIQQL! 9! Cleavage and polyadenylation specificity factor subunit 2!
 ! AAFLKAIGY! 9! Splicing factor 3B subunit 1!
 ! AAMPRPVSY! 9! Kelch-like protein 24!
 ! AASSIQRVL! 9! Alpha-1,2-glucosyltransferase ALG10-A!
 ! AQRMTTQLL! 9! Folate receptor alpha precursor!
 ! DVIYPMAVV! 9! mRNA export factor!
 ! EDDNISVTI! 9! SAFB-like transcription modulator!
 ! EIFADPRTV! 9! Phosphomannomutase 1!
 ! GAFGKPSSL! 9! Uncharacterized protein C19orf21!
 ! GKAPLNVQF! 9! Filamin-B!
 ! ISTPVIRTF! 9! UPF0318 protein FAM120A!
 ! MTPEIIQKL! 9! Pre-mRNA-processing factor 19!
 ! RQADFVQVL! 9! Conserved oligomeric Golgi complex component 6!
 ! SAIDRIFTL! 9! SET domain-containing protein 3!
 ! SAKTPGFSV! 9! Protein AATF!
 ! SAVPFKILY! 9! Receptor-type tyrosine-protein phosphatase F precursor!
 ! TASPLVKSV! 9! Rho GTPase-activating protein 11A!
 ! VAAPQVQQV! 9! Sterol regulatory element-binding protein 2!
 ! VMAPRTLVL! 9! HLA class I histocompatibility antigen, A-2 alpha chain precursor!
 ! ALIEFIRSEY! 10! Threonyl-tRNA synthetase, cytoplasmic!
 ! ETFNTPAMYV! 10! ANKRD26-like family C member 1A!




Table 3.2 Peptides eluted from Hela-T23D3 cells. 
 
MHC! Sequence! Peptide Length! Peptide Origination!
T23! HDLIRVVY! 8! Protein FAM126B!
 ! LPMFIIVV! 8! Sodium/myo-inositol cotransporter!
 ! NIFRNVEV! 8! Ras-related GTP-binding protein A!
 ! SLINEFKL! 8! Taste receptor type 2 member 3!
 ! AAFAYTVKY! 9! Ubiquitin-conjugating enzyme E2 J2!
 ! AAFDKIQQL! 9! Cleavage and polyadenylation specificity factor subunit 2 !
 ! AAFHEEFVV! 9! Fragile X mental retardation syndrome-related protein 1!
 ! AAFLKAIGY! 9! Splicing factor 3B subunit 1 !
 ! AAMPRPVSY! 9! Kelch-like protein 24 !
 ! AKYPEIKSL! 9! Sphingolipid delta(4)-desaturase DES1  !
 ! AQLPEKVEY! 9! Probable global transcription activator SNF2L4  !
 ! DVIYPMAVV! 9! mRNA export factor !
 ! EDDNISVTI! 9! SAFB-like transcription modulator !
 ! EIFADPRTV! 9! Phosphomannomutase 1 !
 ! ETYPDAVKI! 9! Non-structural maintenance of chromosomes element 1 homolog  !
 ! FAYPAIRYL! 9! Mitochondrial 28S ribosomal protein S29  !
 ! FGFHKPKMY! 9! Protein FAM60A !
 ! FVPAEKIVI! 9! Interleukin-20 receptor alpha chain precursor !
 ! GKAPLNVQF! 9! Filamin-B !
 ! GQLPGLHEY! 9! Nuclear protein localization protein 4 homolog !
 ! HSAEILAEI! 9! Anamorsin !
 ! HTANIQTLI! 9! Protein CASC5 !
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MHC! Sequence! Peptide Length! Peptide Origination!
T23! ISTPVIRTF! 9! UPF0318 protein FAM120A !
 ! KLFGSTSSF! 9! Complement decay-accelerating factor precursor  !
 ! LAAQILAVL! 9! Transmembrane protein 101!
 ! MTPEIIQKL! 9! Pre-mRNA-processing factor 19 !
 ! RQADFVQVL! 9! Conserved oligomeric Golgi complex component 6 !
 ! SAIDRIFTL! 9! SET domain-containing protein 3 !
 ! SAIPHPLIM! 9! COP9 signalosome complex subunit 2 !
 ! SAKTPGFSV! 9! Protein AATF !
 ! SAVPFKILY! 9! Receptor-type tyrosine-protein phosphatase F precursor !
 ! TASPLVKSV! 9! Rho GTPase-activating protein 11A !
 ! VMAPRTLIL! 9! HLA class I histocompatibility antigen, Cw-3 alpha chain precursor !
 ! VMAPRTLVL! 9! HLA class I histocompatibility antigen, A-2 alpha chain precursor !
 ! ALIEFIRSEY! 10! Threonyl-tRNA synthetase, cytoplasmic !
 ! ETFNTPAMYV! 10! ANKRD26-like family C member 1A !
 ! VFGPILASLL! 10! Small G protein signaling modulator!
 ! YAYDGKDYIA! 10! HLA class I histocompatibility antigen, A-2 alpha chain precursor  !
 ! RAFDQGADAIY! 11! Cytochrome b-c1 complex subunit 9 !
 ! RKLEAAEDIAY! 11! Prohibitin !





Figure 3.8 Peptide elution from Hela-T11D3 and Hela-T23D3 cells. (A) Length 
distribution of the eluted peptides. The unique peptides from the T23 eluted and T11 
eluted peptide pool were analyzed. Number of 8mer, 9mer and 10mer peptides were 
shown in the Venn diagram. (B) Sequence logo of the total eluted unique peptides from 
T23 and T11. Each column represents one amino acid position in the peptide. Amino 































peptides from endogenous protein that could select CTLs responding to antigen 
processing deficient cells (41). The hybrid T23 on Hela cells predominantly binds the 
human version of Qdm, the peptide generated from HLA-A2 expressed in Hela, as shown 
by the peptide elution assay. In contrast, Qdm peptide was eluted from Hela-T11D3 not 
more frequently than other peptides. Qdm was found only once in the T11 eluted peptide 
pool and it was the only MHC-originated peptide found in the T11 peptide pool. It seems 
likely that the expression of T11D3 on Hela cell surface is stabilized by diverse peptides 
generated from human proteins other than MHC. Although Hela cells are TAP+/+, it is 
still not known whether those eluted peptides require TAP for their presentation. The 
TAP deficient T2 cells also express T11D3 on their surface at comparable level to Hela. 
The T11 on T2 cells may bind the same peptides as the ones on Hela. It is also possible 
that on T2 cells, some of the T11 binding grooves are empty, since T11D3 can fold with 
#2m in the absence of exogenous peptides in the in vitro folding assay. Another 
possibility is that T11 binds various self-originated peptides like Qa-1b does in the TAP 
deficient cells (41), providing a mechanism for the immune system to recognize TAP 
deficient cells based on the expression of a set of peptides that are not expressed in 
normal cells.  
Classical MHC requires binding of peptides for their stable expression. The 
peptide binding groove in MHC class II molecules is occupied by CLIP before the 
loading of antigenic peptides through peptide exchange mechanisms (42). MHC class Ia 
molecules have very fast recycling rates on the cell surface in the absence of bound 
peptides, unless the cells are incubated with the MHC class I specific peptides (43). One 
special property of MHC class Ib molecules is that some of them can exit without any 
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peptide bound, such as thymic leukemia antigen encoded by T18d (34, 44). The two 
alpha helices of TL positioned close to each other such that the binding groove is closed 
(45). T23D3 did not fold with #2m in the absence of peptides. T11D3 folded with #2m 
without the addition of peptides. Protein sequence alignment of T11 and T23 showed that 
there were seven amino acid mutations at the alpha helix motifs, which formed the 
peptide-binding groove. Those mutations may change the conformation of the T11 
groove, makes it slightly stable without bound peptide. This difference in conformation 
might also be responsible for the inability of T11 to present insulin to 6C5 T cells. This 
could be a consequence of changes in the TCR interaction surface or alterations on the 
conformation of bound peptide.      
T23D3 tetramers recognize half of the natural killer cells, which is in consistent 
with previous findings that ~50% of the natural killer cells express CD94/NKG2 (13-18). 
T11 tetramer made by the folded T11D3-#2m-Qdm could not recognize any receptor on 
C57BL/6 NK cells or any other cell types in the organs examined. This again suggests 
that T11 is functionally different from T23, and that it cannot serve as a ligand for 
inhibitory receptors in NK cells. From the peptide elution experiments, Qdm was 
detected on T11 with no greater frequency than other peptides. Unlike T23, Qdm does 
not appear to be the dominant peptide presented by T11 molecules. 
Peptide elution showed that T11 bound fewer peptides than T23, suggesting that 
the structure of T11 might be less flexible than that of T23. Although Qdm was eluted 
from both T11 and T23 transduced Hela cells, it was more frequently found in the T23 
peptide pool, suggesting that Qdm is the dominant peptides bind to T23, but the case 
might not be the same for T11. There were fewer peptides eluted from T11 than T23. It 
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might be that empty T11 is more stable than T23, that some of the hybrid T11 
molecules were transported to Hela cell surface without peptides bound. 
Although T11 does not seem to be a ligand for the NK receptors, various peptides 
were eluted from the Hela-T11D3 cells, suggesting T11 has antigen presentation function. 
T11 is transcribed in major lymphoid organs, spleen and thymus. The expression level 
was high in the thymus, suggesting that T11 may function as a restriction element for T 
cell development. TLA and MR1 restrict T lymphocytes with innate characteristics in the 
intestinal mucosa (46, 47). T11 is also transcribed at relatively high level in intestine, 
suggesting T11 may have some function in the intestine that T cells selected in the 
thymus by T11 may migrate to intestine for their further functions. An E.coli derived 
peptide was eluted from the T11 in vitro folding product (SMEALKPIL) (data not 
shown). The peptide was conserved in multiple bacteria, such as Salmonella enterica, 
Citrobacter freundii and Yersinia enterocolitica, suggesting that T11 has the capability to 
bind bacteria peptides and may restrict T cell anti-bacterial responses. Further studies are 
needed to investigate the functions of T11. 
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 CHAPTER 4 
DISCUSSION 
Summary of findings 
This thesis is focused on the study of nonclassical major histocompatibility 
complex molecules (MHC class Ib). MHC class Ib molecules are expressed at relatively 
low levels compared to MHC class Ia molecules and most of them also have a restrained 
expression pattern. Yet there are so many types of MHC class Ib molecules that they still 
make important contribution to the immune system.  
Chapter 2 of the thesis was focused on the CD8+ T cell anti-LCMV responses in 
MHC class Ia deficient mice. The CD8+ T cells in Ia deficient mice expanded in vivo 
after acute viral infection and produced cytokines and cytotoxic factors. The virus 
infection was partially controlled at the early phase in a #2-microglobulin dependent and 
CD8+ T cell dependent manner. The CD8+ T cell response was restricted by yet to be 
identified MHC class Ib molecules. The mice lacking MHC class Ia were not able to 
completely clear the virus infection and the infection became chronic, accompanied by 
exhaustion and death of the CD8+ T cells. 
Chapter 3 focused on an MHC class Ib gene, H2-T11, which has high similarity to 
the Qa-1b encoding gene, H2-T23. T11 was transcribed at high levels in the major 
immune organs including spleen and thymus, and the hybrid T11 was detected on the cell 
surface at similar level to hybrid Qa-1b, indicating the likelihood that T11 is a
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protein-encoding gene and not a pseudogene. T11 could fold in vitro with or without 
Qdm peptide, and Qdm could bind to the folded T11 molecules as long as Qdm was 
included during the folding process. Folded T11 had a typical MHC class I secondary 
structure based on circular dichroism spectra. T23/Qdm tetramers could recognize NK 
and NKT cells as expected, but T11/Qdm tetramer failed to recognize any examined cell 
types. Peptide elution showed T11 and T23 shared many peptides, including Qdm, but 
Qdm was more commonly found in T23 elution products than T11.  
 
MHC class Ib restricted anti-LCMV response 
CD8+ T cell mediated immune responses play critical role in the defense against 
intracellular pathogen infections. The majority of the CD8+ T cells in wild type animals 
are selected by MHC class Ia molecules in the thymus. The MHC class Ib molecules 
usually have low expression level and limited tissue distribution, but there are so many 
types of MHC class Ib molecules, that in theory, a number of CD8+ T cells are restricted 
by the various MHC class Ib molecules. It’s impossible to determine how many cells are 
restricted by MHC class Ib molecules in the wild type animals. The Kb-/-Db-/- mice do not 
express MHC class Ia. When Kb-/-Db-/- CD8+ T cells were transferred to lymphopenic B6, 
Kb-/-Db-/- or #2m-/- mice, they undergo homeostatic expansion only in B6 and Kb-/-Db-/- 
mice, but not in #2m-/- mice, suggesting that many of the CD8+ T cells in Kb-/-Db-/- mice 
have specificity for #2m-bearing MHC class Ib molecules (1). In Kb-/-Db-/- mice, the 
MHC class Ib restricted T cells represent less than 1% of the total lymphocyte population 
in mouse spleen and inguinal lymph nodes (1). But when the CD4+ T cells are also 
deficient, the CD8+ T cell population grows up to 15% in the iLN and to 5% in the 
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spleen due to homeostatic expansion (1). The CD8+ T cells in the Kb-/-Db-/- and Kb-/-Db-/-
CIITA-/- mice show activated phenotypes (1). 
LCMV-Arm infection usually induces acute infection in mice, followed by 
dramatic expansion of CD8+ T cells within a week post infection (2-6). The virus is 
cleared in 1 to 2 weeks after the infection; the majority of the effector CD8+ T cells die 
by apoptosis and a small fraction becomes memory cells (7). The majority of the effector 
CD8+ T cells are restricted by H2-Db and H2-Kb with the dominant peptides generated 
from LCMV glycoprotein (GP) and nucleoprotein (NP) (8). Our study showed that MHC 
class Ib molecules could also restrict a CD8+ T cell response against LCMV virus, 
together with studies from other groups, suggesting a general role MHC class Ib 
molecules participating in the anti-viral immune response. The MHC class Ib restricted 
CD8+ T cells were few in number, probably due to the limited availability of the Ib 
molecules for their selection in the thymus and for their homeostatic maintenance in the 
peripheral (9, 10). Upon acute viral infection, the few MHC class Ib restricted CD8+ T 
cells responded more vigorously than the Ia restricted CD8+ T cells such that each cell 
produced more granzyme B. The cells continuously produced IFN! until late time points 
after infection. It looks like that the few Ib restricted CD8+ T cells reacted as much as 
they could to compensate for the scarcity of cell number. But still, the total response was 
not strong enough to fully inhibit viral replication, such that in the MHC class Ia deficient 
mice, the CD8+ T cells gradually lose their ability to expand and to produce IFN!, 




H2-M3 selects a subset of CD8+ T cells specifically recognizing Listeria 
monocytogene peptide f-MIGWIIA (14). These CD8+ T cells responded earlier than the 
classical CD8+ T cells; in addition to that, H2-M3 restricted cells did not show enhanced 
expansion upon secondary challenge, indicating the lack of memory responses (15, 16). 
The CD8+ T cells in LCMV infected Kb-/-Db-/-CIITA-/- mice also show early production 
of IFN! and granzyme B, suggesting that MHC class Ib restricted T cells may function 
between the innate and adaptive responses. 
MHC class Ia deficient Kb-/-Db-/- mice were reported to control the chronic !-
herpes 68 virus (!HV68) infection to the same extent as the wild type mice, and better 
than the CD8-/-, #2m-/-, and Kb-/-Db-/-#2m-/- mice, indicating the importance of MHC class 
Ib-restricted CD8+ T cell response during !HV68 infection (17). The nonclassical CD8+ 
T cells expanded to similar numbers as those in B6 mice after 6 weeks of infection, and 
the T cells had a TCR usage skewed toward V#4. More than 60% of CD8+ T cells in Kb-/-
Db-/- mice expressed V#4 after 6 weeks of infection (17). The V# usage analysis in 
LCMV-Arm infected Kb-/-Db-/-CIITA-/- mice showed that CD8+ T cells have multiple V# 
usage with slight skewing toward V#8.1/V#8.2, V#10 and V#13. This indicates that class 
Ib restricted CD8+ T cells may have more diversified response to LCMV than to !HV68. 
A population of Q9 restricted CD8+ T cells was identified in polyoma virus 
(PyV) infected Kb-/-Db-/- mice (18). The CD8+ T cells specifically recognize a peptide 
from the virus VP2 protein. The VP2 specific, Q9-restricted CD8+ T cells were dominant 
in the Kb-/-Db-/- mice, but in contrast to the large proportion of PyV specific, MHC class Ia 
restricted CD8+ T cells, Q9-restricted CD8+ T cells represented only a very small 
fraction of the total T cell response in the PyV-infected B6 mice. Class Ia restricted T 
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cells might compete with the Ib restricted T cells for proliferation and survival factors. 
Low expression levels of Ib molecules in the wild type mice may also limit the expansion 
of the Ib restricted T cells.  
Notably, both !HV68 and PyV viruses induce chronic infections even in wild type 
animals. Class Ib restricted CD8+ T cells have the ability to control these virus infections 
to a low level, but they were not able to clear the infections, neither do the Ia restricted 
CD8+ T cells. MHC class Ib restricted CD8+ T cells may also play roles in other chronic 
viral infections. It seems that class Ib restricted T cells behave differently when 
combatting acute viral infections rather than chronic infection. During our study, in 
which LCMV-Arm was used as the model pathogen, class Ia deficient mice were able to 
partially control the acute viral infection at the early phase, but failed to clear the virus 
infection in long-term, indicating that rapid viral replication might overwhelm the Ib-
restricted CD8+ T cell response.  
MHC class Ib restricted CD8+ T cells may participate in various infections as do 
Ia restricted CD8+ T cells. It is hard to determine their importance in the anti-microbial 
response without knowing the exact restricting MHC class Ib molecules and the ligands 
they bind. In only one case has the specificity of class Ib-restricted anti-viral CD8+ T 
cells been defined (Q9/VP2 in mouse polyoma virus infection). There are about 40 MHC 
class Ib genes in the mouse and 20 genes in human. Most of them have not been studied 
and some of them may have interesting functions (19). To figure out which MHC class Ib 
molecule/molecules might restrict the anti-LCMV response, T cells from LCMV-infected 
Kb-/-Db-/-CIITA-/- mice were restimulated by MHC class Ib knockout APCs or APCs 
blocked by MHC class Ib antibodies; no significant T cell response reduction was 
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observed. A reduction was observed when the T cells were stimulated with Qa-2-/- APCs, 
suggesting that Qa-2 might restrict partial Kb-/-Db-/-CIITA-/- T cell response against 
LCMV. Multiple Ib molecules might be involved in the anti-LCMV response. It is also 
possible that the response might be restricted by some yet-to-be studied MHC class Ib 
molecule/molecules. 
Class Ia knockout mice provide us with a useful tool to study the functions of Ib 
molecules (20). Class Ib restricted T cell responses were examined by directly 
inoculating the Ia knockout mice with pathogens (17, 18, 21). Most if not all the studies, 
including this one, showed that MHC class Ib molecules could restrict T cell responses, 
and these T cells responded by producing cytokines and cytotoxic factors earlier than the 
Ia-restricted T cells and lacked memory response (15, 16, 21-25). Although the Ib 
restricted CD8+ T cells may only compose a very small fraction of the total CD8+ T cell 
repertoire in wild type mice, they have the capacity to expand to large population upon 
microbial infections. The class Ib restricted T cells may bridge the innate and adaptive 
immune responses (25).  
 
T11 as a functional paralog of T23 
There are over 40 MHC class Ib genes in the mouse, most of which are encoded 
in the mouse MHC region telomeric end and are not characterized. Genetic studies 
suggest that these genes originated from gene duplication; as mutations gathered during 
evolution, they gradually diverged from each other after the duplication, such that some 
of them have lost their original functions and some of them have gained new functions 
(26-33). The genes duplicated recently may not have enough mutations and still retain 
original functions. H2-T11 might have duplicated from H2-T23 as they share high 
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similarity in gene sequence such that the putative proteins that they encode also retain 
high identity in amino acid sequence. T23 encodes the Qa-1b protein, which binds Qdm 
peptides and presents them to the CD94/NKG2A inhibitory receptors on NK and NKT 
cells. T11 hybrid molecules were expressed efficiently on Hela and T2 cell surfaces at 
levels comparable to T23, suggesting that expression of T11 on cell surface is 
independent of TAP machinery. The 6A8 antibody made to detect the Qa-1b "2 domain, 
also weakly recognized T11, suggesting T11 shares the same or a similar 6A8 recognized 
epitope within T23. The hybrid T11 recombinant protein could fold in vitro with or 
without Qdm peptide, and the folding efficiency was better with the addition of Qdm 
peptide to the folding reaction, suggesting the Qdm peptides helped to stabilize the MHC 
structure. But to our surprise, the T11/Qdm tetramer, although made with Qdm peptides, 
did not bind to CD94/NKG2 receptors on NK or NKT cells. This suggested that T11 does 
not have the same function as T23 to regulate NK cell function. This could be because of 
the amino acid change at the contact interface of MHC/NK receptor, poor binding of 
Qdm peptide, or indirect conformational changes compared to T23/Qdm that affect NK 
receptor binding. Estimated from the HLA-E/CD94/NKG2A co-crystal structure, the 
change at T11 position 85 from tryptophan to arginine might interfere the interaction 
between T11 and CD94/NKG2A.   
We identified peptides eluted from class Ib molecules purified from Hela cells 
expressing T23 or T11 hybrid molecules. This result provides strong evidence that T11 
has the capacity to bind peptide ligands (unlike TLA), and it suggests that it can bind 
diverse peptide sequences. Qdm was found in both T23 and T11 elution products, but 
was much more abundant in the T23 elution repertoire than in the T11 repertoire, which 
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is consistent with previous studies demonstrating that Qdm is the dominant peptide 
binding to T23 (34, 35). The Qa-1b /Qdm crystal structure reveals the features of the 
peptide binding groove that allow Qa-1b to preferentially bind Qdm peptides (36). The 
alignment of T11 protein to the Qa-1b protein shows that all the amino acids that form 
van der Waals and hydrogen bonds with Qdm peptides are conserved. The majority of the 
peptides eluted from T11 could be found in the T23 elution products, indicating 
significant conservation between T11 and T23 in peptide binding specificity. There are 
two amino acid changes at the bottom of the peptide-binding groove, T9H and A11V. 
The change of threonine to histidine may interfere with the interaction between T11 and 
Qdm, favoring the formation of a salt bridge between T11 and bound peptide. In fact, an 
E.coli derived peptide with a glutamic acid at peptide position 3 was eluted from the T11 
in vitro folding product (SMEALKPIL), and the glutamic acid was in a potentially good 
position to interact with the T11 histidine. Whether this peptide can really bind T11 is 
under investigation. There are also several amino acid changes in the "-helixes of the 
peptide-binding groove, which may also slightly alter the T11 conformation and change 
the peptide-binding pattern.  
A similar strategy was used to express a Qa-1b hybrid molecule in TAP deficient 
mouse cell line EC7.1 and peptides were eluted from the hybrid Qa-1b molecules (37). 
The hybrid molecule expressed the H2-Db "3 domain and antibody against this domain 
was used to precipitate the MHC. The peptides eluted had a motif with dominant 
asparagine at position 5 and the motif pattern was very close to the motif pattern of H2-
Db binding peptides (38), which make us suspect that the peptides were actually derived 
from Db molecules but not from the hybrid Qa-1b. Although EC7.1 cell is TAP deficient 
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and Db molecules are not detectable on the cell surface by flow cytometry, Db molecules 
are still synthesized and assembled inside EC7.1 cells and Db molecules may be present 
in these cell bearing self-originated peptides present inside the ER. 
Although T11 does not seem to have the same function as T23, it is transcribed at 
high level in thymus, suggesting the possibility that it may participate in the T cell 
maturation process. Qa-1b/H2-T23 select a subset of T cells specific for insulin in the 
thymus (39). T11 may also act as a restriction element to select T cells. T11 is also 
transcribed at relatively high level in spleen and intestine, suggesting it may present 
antigens to the T cells in the peripheral. The relatively high T11 expression level in the 
intestine provides the possibility that T11 might interact with the innate CD8""+ T cells 
or !(+ T cells in the intestine, like MR1 and TLA do.   
Mouse Qa-1b molecule shares 73% amino acid identity with human HLA-E, and 
they have similar functions in presentation of Qdm or Qdm-like peptides to specifically 
interact with CD94/NKG2 receptors, this regulating the activation of NK and NKT cells 
(40-42). The amino acid identity between T11 and HLA-E is 71% identical. T11 and 
HLA-E might have evolved independently, like T23 and HLA-E (43). But T11 seems to 
have evolved in different directions from T23 and HLA-E, such that T11 does not retain 
this dominant function in regulating NK cell activation.  
Although the hypothesis that T11 may have similar functions to Qa-1b/H2-T23 
was proved not true, the peptides eluted from Hela-T11D3 cells will be useful to further 
study T11 function. The synthesized peptides may be used to immunize MHC class Ia 
deficient mice to see whether they can induce T11-restricted T cell response. The 
immunized mice T cells may be re-stimulated in vitro with the T11 expressing cell line in 
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the existence of the peptides. Tetramers can also be made by the recombinant T11 folded 
with the synthesized peptides; the new tetramer may be used to stain mouse cells to find 
the potential receptors.  
Studies on MHC class Ib molecules indicated that some of them have unique 
properties and important functions. H2-T23 deficient mice had much higher virus burden 
than wild type mice when infected with mouse poxvirus, indicating the essential role for 
H2-T23 during the virus infection (44). Besides immune functions, some nonclassical 
MHC class I molecules have special functions other than presenting antigens. Neonatal 
Fc receptor (FcRn) can bind and release IgG antibodies in pH dependent manner and help 
the transportation of IgG from the mother to the fetus, providing passive immunity to the 
fetus (45). Another nonclassical MHC class I molecule, HFE, binds transferrin receptor 1, 
and mutation of HFE is associated with hereditary hemochromatosis (46). Both FcRn and 
HFE fold with #2m but do not bind peptides. Some MHC-like molecules even do not 
bind #2m, such as Zn-"2-glycoprotein (ZAG) (47). There are many MHC class Ib 
molecules that remain to be studied. Our research on T11 provides more information on 




This thesis focused on MHC class Ib molecules and the CD8+ T cell responses 
restricted by them. It proved that the MHC class Ib restricted CD8+ T cells were able to 
respond to viral infections by proliferating and secreting effective factors just like 
classical CD8+ T cells do; but the virus could only be partially cleared during the early 
phase of the infection in MHC class Ia deficient mice; MHC class Ib restricted CD8+ T 
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cells continually respond to the uncleared viral infection and eventually lost function. The 
study of a specified MHC, H2-T11, proved that although H2-T11 has very similar 
sequence to H2-T23, and shares many binding peptides with T23, it has different 
functions from T23. T11/insulin does not activate Qa-1b/insulin specific T cell 
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